microRNA information: hsa-miR-125b-5p

SectionIDlink
Mature name: hsa-miR-125b-5pmiRbase
Accession: MIMAT0000423miRbase
Precursor name: hsa-mir-125b-1 miRbase
Precursor accession: MI0000446miRbase
Symbol: MIR125B1HGNC
RefSeq ID: NR_029671GenBank
Sequence: UCCCUGAGACCCUAACUUGUGA



Reported expression in cancers: hsa-miR-125b-5p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-125b-5p

acute myeloid leukemiaupregulation"Myeloid cell differentiation arrest by miR 125b 1 ......"18936236
hsa-miR-125b-5p

acute myeloid leukemiaupregulation"This paper evaluated the association between micro ......"25646775RNA-Seq
hsa-miR-125b-5p

bladder cancerdownregulation"We identified a subset of 7 miRNAs miR-145 miR-30a ......"19378336qPCR
hsa-miR-125b-5p

bladder cancerdownregulation"microRNA-125b miR-125b was implicated to have clos ......"20549700
hsa-miR-125b-5p

bladder cancerdownregulation"In the first - discovery - phase microarray cards ......"27468885Microarray; qPCR
hsa-miR-125b-5p

breast cancerdownregulation"MiR-125b is one of the known down-regulated miRNAs ......"20978686
hsa-miR-125b-5p

breast cancerdownregulation"The microRNA miR-125b is dysregulated in various h ......"21444677
hsa-miR-125b-5p

breast cancerdownregulation"To compare the carcinogenic process in tumors with ......"24810926qPCR
hsa-miR-125b-5p

breast cancerdownregulation"Dysregulated miR-125 observed in multiple cancer t ......"26782438qPCR
hsa-miR-125b-5p

breast cancerdownregulation"Among the differentially expressed miRNAs in breas ......"27226726
hsa-miR-125b-5p

breast cancerdownregulation"Downregulation of miR-125b-1 is associated with po ......"27386402
hsa-miR-125b-5p

cervical and endocervical cancerupregulation"OCT4 induces upregulation of miR-125b through dire ......"23928699
hsa-miR-125b-5p

colorectal cancerdownregulation"MicroRNA miR 125b is a prognostic marker in human ......"21399871qPCR
hsa-miR-125b-5p

colorectal cancerdownregulation"The study was divided into two phases: firstly qRT ......"25255814qPCR; Microarray
hsa-miR-125b-5p

colorectal cancerdownregulation"The expression levels of the two miRNAs were deter ......"26693202Reverse transcription PCR; qPCR
hsa-miR-125b-5p

colorectal cancerdownregulation"Screening miRNAs for early diagnosis of colorectal ......"27022275RNA-Seq
hsa-miR-125b-5p

esophageal cancerdownregulation"HPV 16 E6 promotes cell growth of esophageal cance ......"26722596
hsa-miR-125b-5p

gastric cancerderegulation"miRNA expression signature was first analyzed by r ......"21628394qPCR
hsa-miR-125b-5p

gastric cancerdownregulation"In this study we found that the expression levels ......"26504803
hsa-miR-125b-5p

gastric cancerupregulation"Here we investigate the role of miR-125b in gastri ......"27220320
hsa-miR-125b-5p

glioblastomaupregulation"Accumulating evidence indicates that microRNA miR- ......"23857508
hsa-miR-125b-5p

head and neck cancerdownregulation"To identify miRNAs associated with head and neck s ......"23416980
hsa-miR-125b-5p

head and neck cancerdownregulation"Conversely decreased expressions of miR-153 miR-20 ......"25677760
hsa-miR-125b-5p

kidney renal cell cancerderegulation"This study aims to profile dysregulated microRNA m ......"25938468Microarray
hsa-miR-125b-5p

liver cancerdownregulation"In this study we demonstrated the down-regulation ......"22942733Northern blot; qPCR
hsa-miR-125b-5p

liver cancerdownregulation"We have previously reported frequent down-regulati ......"22991213
hsa-miR-125b-5p

liver cancerdownregulation"ERManI is a target of miR 125b and promotes transf ......"23940818Microarray
hsa-miR-125b-5p

liver cancerdownregulation"This study investigates the involvement of miR-125 ......"24811246qPCR
hsa-miR-125b-5p

liver cancerdownregulation"Among these miRNAs miR-125b expression was most st ......"25953743
hsa-miR-125b-5p

lung cancerupregulation"Notably ectopic expression of miR-125b led to the ......"26351908
hsa-miR-125b-5p

lung squamous cell cancerdownregulation"Circulating miR 125b is a novel biomarker for scre ......"22806310Reverse transcription PCR
hsa-miR-125b-5p

melanomadownregulation"Downregulation of miR 125b in metastatic cutaneous ......"20827223Microarray; Reverse transcription PCR
hsa-miR-125b-5p

melanomadownregulation"In a previous study we found that the expression o ......"21460750
hsa-miR-125b-5p

ovarian cancerdownregulation"miR-125b has essential roles in coordinating tumor ......"25944662
hsa-miR-125b-5p

ovarian cancerdownregulation"miRNA mimics and miRNA inhibitors were used in qua ......"26646586qPCR
hsa-miR-125b-5p

prostate cancerupregulation"Our previous studies demonstrated that in human pr ......"23585871
hsa-miR-125b-5p

sarcomadownregulation"This study is aimed to investigate the clinical im ......"26330295qPCR
hsa-miR-125b-5p

sarcomadownregulation"We report miR-125b was downregulated in both chond ......"26966351
hsa-miR-125b-5p

sarcomadownregulation"The expression of miR-125b in human chondrosarcoma ......"27576314qPCR



Reported cancer pathway affected by hsa-miR-125b-5p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-125b-5p

bladder cancerApoptosis pathway"Hsa miR 125b suppresses bladder cancer development ......"24396870
hsa-miR-125b-5p

bladder cancerApoptosis pathway"Hsa miR 125b suppresses bladder cancer development ......"24512851
hsa-miR-125b-5p

bladder cancercell cycle pathway"MicroRNAs miRNAs are small non-coding RNAs 18-25 n ......"26807182Colony formation; Luciferase; Western blot
hsa-miR-125b-5p

breast cancerApoptosis pathway"In this study we utilized a miRNA array to compare ......"20460378
hsa-miR-125b-5p

breast cancercell cycle pathway"miR 125b is methylated and functions as a tumor su ......"21444677
hsa-miR-125b-5p

breast cancerApoptosis pathway"Functional cooperation of miR 125a miR 125b and mi ......"23519125
hsa-miR-125b-5p

breast cancerEpithelial mesenchymal transition pathway"miR 125b regulates side population in breast cance ......"23606360
hsa-miR-125b-5p

breast cancercell cycle pathway"miR 125b acts as a tumor suppressor in breast tumo ......"24098452
hsa-miR-125b-5p

breast cancerEpithelial mesenchymal transition pathway"MiR 125b regulates epithelial mesenchymal transiti ......"25605244
hsa-miR-125b-5p

breast cancerApoptosis pathway"The role of miR 125b mitochondria caspase 3 pathwa ......"25894378Luciferase
hsa-miR-125b-5p

breast cancercell cycle pathway"We demonstrate that resveratrol regulates apoptoti ......"26890143
hsa-miR-125b-5p

breast cancerEpithelial mesenchymal transition pathway"miR 125b inhibited epithelial mesenchymal transiti ......"27226726
hsa-miR-125b-5p

cervical and endocervical cancerApoptosis pathway; mTOR signaling pathway"MiR 125b inhibits tumor growth and promotes apopto ......"23160634Flow cytometry; MTT assay
hsa-miR-125b-5p

cervical and endocervical cancerApoptosis pathway"OCT4 induces upregulation of miR-125b through dire ......"23928699Luciferase
hsa-miR-125b-5p

cervical and endocervical cancerApoptosis pathway"MicroRNAs as biomarkers of cervical cancer develop ......"24402874
hsa-miR-125b-5p

gastric cancercell cycle pathway; Apoptosis pathway"Expression profiling and functional analysis of hs ......"24846940
hsa-miR-125b-5p

gastric cancerApoptosis pathway"miR 125b Suppresses Proliferation and Invasion by ......"26504803
hsa-miR-125b-5p

glioblastomaApoptosis pathway"MiR 125b acts as an oncogene in glioblastoma cells ......"24169356Colony formation; Luciferase; Western blot
hsa-miR-125b-5p

glioblastomacell cycle pathway"miR 125b promotes cell proliferation by directly t ......"24356103
hsa-miR-125b-5p

glioblastomaApoptosis pathway"miR 125b inhibitor enhance the chemosensitivity of ......"24643683
hsa-miR-125b-5p

glioblastomaApoptosis pathway; cell cycle pathway"miR 125b controls apoptosis and temozolomide resis ......"24901050
hsa-miR-125b-5p

head and neck cancercell cycle pathway"A global miRNA profiling was done on 51 formalin-f ......"20145181Flow cytometry
hsa-miR-125b-5p

liver cancercell cycle pathway"Our previous study showed that miR-125b was a prog ......"20827722
hsa-miR-125b-5p

liver cancercell cycle pathway"In this study we demonstrated the down-regulation ......"22942733
hsa-miR-125b-5p

liver cancercell cycle pathway"Sirtuin7 oncogenic potential in human hepatocellul ......"23079745
hsa-miR-125b-5p

lung cancerEpithelial mesenchymal transition pathway"Up regulation of miR 125b reverses epithelial mese ......"26351908
hsa-miR-125b-5p

lung cancerEpithelial mesenchymal transition pathway"Retraction Note to the article "Up regulation of m ......"26356362
hsa-miR-125b-5p

lymphomaApoptosis pathway"Aberrant expression of oncogenic miRNAs including ......"24479800
hsa-miR-125b-5p

melanomaApoptosis pathway"MicroRNA miR 125b induces senescence in human mela ......"21460750
hsa-miR-125b-5p

melanomacell cycle pathway"miR 125b induces cellular senescence in malignant ......"24762088Western blot; Flow cytometry
hsa-miR-125b-5p

melanomaEpithelial mesenchymal transition pathway"Here we used in silico analysis of microRNA expres ......"26968260
hsa-miR-125b-5p

ovarian cancercell cycle pathway"MiR 125b targets BCL3 and suppresses ovarian cance ......"20658525
hsa-miR-125b-5p

ovarian cancerApoptosis pathway"miR 125b confers resistance of ovarian cancer cell ......"21823019Flow cytometry; Western blot; Luciferase
hsa-miR-125b-5p

ovarian cancerApoptosis pathway"miRNA mimics and miRNA inhibitors were used in qua ......"26646586Western blot; Luciferase
hsa-miR-125b-5p

ovarian cancerEpithelial mesenchymal transition pathway"MicroRNA-125b miR-125b is overexpressed in several ......"27383536Western blot; Luciferase
hsa-miR-125b-5p

prostate cancerApoptosis pathway"Oncomir miR 125b suppresses p14ARF to modulate p53 ......"23585871
hsa-miR-125b-5p

retinoblastomacell cycle pathway"Among them hsa-miR-373 hsa-miR-125b and hsa-miR-18 ......"26730174
hsa-miR-125b-5p

retinoblastomaApoptosis pathway"The miRNA miR-125b is dysregulated in various huma ......"27518550Luciferase
hsa-miR-125b-5p

sarcomacell cycle pathway; Apoptosis pathway; mTOR signaling pathway"MiR 125b inhibits cell biological progression of E ......"24517182Western blot



Reported cancer prognosis affected by hsa-miR-125b-5p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-125b-5p

B cell lymphomadrug resistance; progression; recurrence; worse prognosis; poor survival"Then from eight potential drug-resistant miRNAs wh ......"26870228
hsa-miR-125b-5p

acute myeloid leukemiadifferentiation"Myeloid cell differentiation arrest by miR 125b 1 ......"18936236
hsa-miR-125b-5p

bladder cancerdifferentiation; tumorigenesis"microRNA-125b miR-125b was implicated to have clos ......"20549700Luciferase
hsa-miR-125b-5p

bladder cancercell migration; metastasis"The expression of microRNA-125b miR-125b has been ......"23425975Western blot; Luciferase
hsa-miR-125b-5p

bladder cancermalignant trasformation"We screened 723 miRNAs by microarray and selected ......"23945108
hsa-miR-125b-5p

bladder cancermotility"Hsa miR 125b suppresses bladder cancer development ......"24396870
hsa-miR-125b-5p

bladder cancermotility"Hsa miR 125b suppresses bladder cancer development ......"24512851
hsa-miR-125b-5p

bladder cancerprogression; poor survival"Of the eight most important progression-related mi ......"25990459
hsa-miR-125b-5p

bladder cancerpoor survival"We identified an eight-miRNA signature including t ......"25991007
hsa-miR-125b-5p

breast cancerpoor survival"A short hairpin DNA analogous to miR 125b inhibits ......"19825990
hsa-miR-125b-5p

breast cancerdrug resistance"In this study we utilized a miRNA array to compare ......"20460378
hsa-miR-125b-5p

breast cancermotility"Expression profiling of 365 miRNA by real-time qua ......"21375733
hsa-miR-125b-5p

breast cancerpoor survival; tumorigenesis; worse prognosis"miR 125b is methylated and functions as a tumor su ......"21444677
hsa-miR-125b-5p

breast cancermotility"miR 125b targets ARID3B in breast cancer cells; Am ......"22307404Cell migration assay
hsa-miR-125b-5p

breast cancerdrug resistance"Circulating MiR 125b as a marker predicting chemor ......"22523546
hsa-miR-125b-5p

breast cancermetastasis"miR-125b is down-regulated in human breast cancer ......"22693547Cell migration assay; Wound Healing Assay; Western blot; Luciferase
hsa-miR-125b-5p

breast cancermetastasis; drug resistance"miR 125b regulates side population in breast cance ......"23606360
hsa-miR-125b-5p

breast cancertumorigenesis"miR 125b acts as a tumor suppressor in breast tumo ......"24098452
hsa-miR-125b-5p

breast cancerdrug resistance"We created a doxorubicin-resistant MCF-7 MCF-/Adr ......"25451164MTT assay
hsa-miR-125b-5p

breast cancerdrug resistance"MiR 125b regulates epithelial mesenchymal transiti ......"25605244
hsa-miR-125b-5p

breast cancerdrug resistance; worse prognosis"To gain further insight into the molecular mechani ......"25633049
hsa-miR-125b-5p

breast cancerdrug resistance"The role of miR 125b mitochondria caspase 3 pathwa ......"25894378Luciferase
hsa-miR-125b-5p

breast cancermalignant trasformation; metastasis; tumor size; progression"Dysregulated miR-125 observed in multiple cancer t ......"26782438
hsa-miR-125b-5p

breast cancerworse prognosis; drug resistance"miR 125b inhibited epithelial mesenchymal transiti ......"27226726
hsa-miR-125b-5p

breast cancerworse prognosis"miR 125b 1 is repressed by histone modifications i ......"27386402
hsa-miR-125b-5p

breast cancerprogression"We identified eight microRNAs miR-10a miR-10b miR- ......"27433802
hsa-miR-125b-5p

breast cancerpoor survival"In this multicenter study a 10-miRNA classifier in ......"27566954
hsa-miR-125b-5p

cervical and endocervical cancerdrug resistance"OCT4 induces upregulation of miR-125b through dire ......"23928699Luciferase
hsa-miR-125b-5p

cervical and endocervical cancerimmune resistance; tumorigenesis"MicroRNAs as biomarkers of cervical cancer develop ......"24402874
hsa-miR-125b-5p

colorectal cancerprogression"Clinicopathological significance of microRNA 21 an ......"19921579
hsa-miR-125b-5p

colorectal cancerstaging; tumor size; worse prognosis; poor survival; progression"MicroRNA miR 125b is a prognostic marker in human ......"21399871
hsa-miR-125b-5p

colorectal cancermetastasis"The expression of miR-106a was found to be upregul ......"24746948
hsa-miR-125b-5p

colorectal cancerworse prognosis"Screening miRNAs for early diagnosis of colorectal ......"27022275
hsa-miR-125b-5p

endometrial cancerstaging"MiR 125b promotes proliferation and migration of t ......"21970405Western blot; Cell migration assay; Wound Healing Assay; Luciferase
hsa-miR-125b-5p

endometrial cancertumorigenesis"The objective of this study was to investigate the ......"22460089Transwell assay; Western blot; Luciferase; RNAi
hsa-miR-125b-5p

esophageal cancertumorigenesis; progression"HPV 16 E6 promotes cell growth of esophageal cance ......"26722596Colony formation
hsa-miR-125b-5p

gastric cancerprogression"353 gastric samples from two independent subsets o ......"20022810
hsa-miR-125b-5p

gastric cancerpoor survival"RNA and protein expression were analyzed by RT-PCR ......"24352645
hsa-miR-125b-5p

gastric cancerdrug resistance"Expression profiling and functional analysis of hs ......"24846940
hsa-miR-125b-5p

gastric cancerworse prognosis; cell migration; staging; metastasis; tumor size"MiR 125b promotes cell migration and invasion by t ......"25240408Western blot; Transwell assay; Luciferase
hsa-miR-125b-5p

gastric cancercell migration"miR 101 2 miR 125b 2 and miR 451a act as potential ......"26458815Western blot; Colony formation
hsa-miR-125b-5p

gastric cancerstaging; metastasis; drug resistance; progression"miR 125b Suppresses Proliferation and Invasion by ......"26504803
hsa-miR-125b-5p

gastric cancermetastasis; staging; cell migration"Here we investigate the role of miR-125b in gastri ......"27220320Luciferase
hsa-miR-125b-5p

glioblastomadrug resistance"MicroRNAs miRNAs are small non-coding RNA molecule ......"21879257
hsa-miR-125b-5p

glioblastomacell migration"Myc associated zinc finger protein MAZ is regulate ......"22415301
hsa-miR-125b-5p

glioblastomastaging"Functional differences of miR 125b on the invasion ......"22711523
hsa-miR-125b-5p

glioblastomamalignant trasformation"In this study we aimed to identify the combined ef ......"23835866Transwell assay
hsa-miR-125b-5p

glioblastomadrug resistance"miR 125b inhibitor may enhance the invasion preven ......"23857508
hsa-miR-125b-5p

glioblastomamalignant trasformation"MiR 125b acts as an oncogene in glioblastoma cells ......"24169356Colony formation; Luciferase; Western blot
hsa-miR-125b-5p

glioblastomaprogression"miR 125b promotes cell proliferation by directly t ......"24356103
hsa-miR-125b-5p

glioblastomadrug resistance"miR 125b inhibitor enhance the chemosensitivity of ......"24643683
hsa-miR-125b-5p

glioblastomapoor survival"An inverse relationship between miR-125b and nesti ......"24817689
hsa-miR-125b-5p

glioblastomadrug resistance; poor survival"miR 125b controls apoptosis and temozolomide resis ......"24901050
hsa-miR-125b-5p

glioblastomastaging"Serum and tissues miRNAs expression in patients wi ......"27476114
hsa-miR-125b-5p

head and neck cancermalignant trasformation; progression"Loss of miR 125b 1 contributes to head and neck ca ......"23416980
hsa-miR-125b-5p

head and neck cancerworse prognosis"Conversely decreased expressions of miR-153 miR-20 ......"25677760
hsa-miR-125b-5p

kidney renal cell cancerpoor survival; recurrence; staging"Tumor miR 125b predicts recurrence and survival of ......"25155155
hsa-miR-125b-5p

kidney renal cell cancerstaging"This study aims to profile dysregulated microRNA m ......"25938468
hsa-miR-125b-5p

kidney renal cell cancerworse prognosis"We found that elevated expression of miR-21 miR-12 ......"26416448
hsa-miR-125b-5p

liver cancerpoor survival; worse prognosis"Then the expressions of 8 differentially expressed ......"18649363
hsa-miR-125b-5p

liver cancertumorigenesis; cell migration"Our previous study showed that miR-125b was a prog ......"20827722
hsa-miR-125b-5p

liver cancermalignant trasformation; cell migration"Our aim was to evaluate the role of aberrantly exp ......"21703189Luciferase
hsa-miR-125b-5p

liver cancerprogression"In this study we demonstrated the down-regulation ......"22942733
hsa-miR-125b-5p

liver cancerstaging"Profiles of serum microRNAs; miR 125b 5p and miR22 ......"24595450
hsa-miR-125b-5p

liver cancerrecurrence; poor survival; worse prognosis; tumorigenesis"This study investigates the involvement of miR-125 ......"24811246Luciferase
hsa-miR-125b-5p

liver cancerdrug resistance; malignant trasformation"The microRNA miR-125 family has been implicated in ......"24865963
hsa-miR-125b-5p

liver cancerdifferentiation; drug resistance; metastasis"Among these miRNAs miR-125b expression was most st ......"25953743
hsa-miR-125b-5p

liver cancerrecurrence; poor survival"In the present study TaqMan Real-time PCR microRNA ......"26176380
hsa-miR-125b-5p

liver cancertumor size"Our previous study has hinted that serum microRNA- ......"27267832
hsa-miR-125b-5p

liver cancermetastasis"MicroRNAs miR 125b and miR 100 suppress metastasis ......"27577856
hsa-miR-125b-5p

lung cancerprogression"We succeeded in establishing the MTA1 knockdown NS ......"22576802RNAi
hsa-miR-125b-5p

lung cancerstaging; metastasis; progression"In this work the methylation of six miRNA genes mi ......"24450160
hsa-miR-125b-5p

lung cancerdrug resistance"Up regulation of miR 125b reverses epithelial mese ......"26351908
hsa-miR-125b-5p

lung cancerprogression; drug resistance"Expression levels of miR-19b miR-126 miR-25 miR-20 ......"26986825
hsa-miR-125b-5p

lung squamous cell cancerworse prognosis; staging; poor survival"Circulating miR 125b is a novel biomarker for scre ......"22806310
hsa-miR-125b-5p

lung squamous cell cancermetastasis; cell migration; progression"MTA1 promotes the invasion and migration of non sm ......"23718732
hsa-miR-125b-5p

lung squamous cell cancercell migration"High expression of kinesin light chain 2 a novel t ......"25668010Luciferase
hsa-miR-125b-5p

lung squamous cell cancermetastasis; staging"Here we evaluated the potential role of miR-125b i ......"26388699Western blot
hsa-miR-125b-5p

lymphomadrug resistance; poor survival"Using cutaneous T-cell lymphoma CTCL as a model of ......"23527180
hsa-miR-125b-5p

lymphomadifferentiation"Aberrant expression of oncogenic miRNAs including ......"24479800
hsa-miR-125b-5p

melanomamalignant trasformation; metastasis; progression"Downregulation of miR 125b in metastatic cutaneous ......"20827223
hsa-miR-125b-5p

melanomametastasis; malignant trasformation"MicroRNA miR 125b induces senescence in human mela ......"21460750
hsa-miR-125b-5p

melanomaprogression; malignant trasformation"MicroRNA miR 125b controls melanoma progression by ......"22797068Luciferase
hsa-miR-125b-5p

melanomamalignant trasformation"Expression of the miRNA miR-125b and serine/threon ......"24635082Cell Proliferation Assay; Western blot; Luciferase
hsa-miR-125b-5p

melanomamalignant trasformation; metastasis; progression"miR 125b induces cellular senescence in malignant ......"24762088Western blot; Flow cytometry
hsa-miR-125b-5p

melanomastaging"To analyze miR-125b levels in serum and in exosome ......"24878024
hsa-miR-125b-5p

melanomaprogression; poor survival; cell migration"Here we used in silico analysis of microRNA expres ......"26968260
hsa-miR-125b-5p

ovarian cancerdrug resistance"High-throughput analysis of the miRNA profile in a ......"18823650
hsa-miR-125b-5p

ovarian cancerdrug resistance"miR 125b confers resistance of ovarian cancer cell ......"21823019Flow cytometry; Western blot; Luciferase
hsa-miR-125b-5p

ovarian cancermetastasis; recurrence; tumorigenesis"PPARγ inhibits ovarian cancer cells proliferation ......"25944662
hsa-miR-125b-5p

ovarian cancercell migration"miRNA mimics and miRNA inhibitors were used in qua ......"26646586Western blot; Luciferase
hsa-miR-125b-5p

ovarian cancerstaging; metastasis"Utility of Serum miR 125b as a Diagnostic and Prog ......"27092777
hsa-miR-125b-5p

ovarian cancerdrug resistance; metastasis; progression; cell migration"MicroRNA-125b miR-125b is overexpressed in several ......"27383536Western blot; Luciferase
hsa-miR-125b-5p

ovarian cancerprogression; poor survival"Using customized TaqMan low density miRNA arrays w ......"27636713
hsa-miR-125b-5p

pancreatic cancerstaging"Based on relevance to cancer a seven-miRNA signatu ......"25184537
hsa-miR-125b-5p

prostate cancermalignant trasformation"In this study we found differential expression of ......"18056640
hsa-miR-125b-5p

prostate cancerstaging"To overcome the lack of reproducibility we profile ......"21212412
hsa-miR-125b-5p

prostate cancerprogression"Aberrant expressions of some miRNAs like miR-221/2 ......"24386864
hsa-miR-125b-5p

prostate cancerstaging; progression"Microarray and Q-RT-PCR analyses identified 43 miR ......"24583788
hsa-miR-125b-5p

prostate cancertumorigenesis; progression"Dual Action of miR 125b As a Tumor Suppressor and ......"26544868Luciferase
hsa-miR-125b-5p

retinoblastomametastasis"Among them hsa-miR-373 hsa-miR-125b and hsa-miR-18 ......"26730174
hsa-miR-125b-5p

retinoblastomastaging"The miRNA miR-125b is dysregulated in various huma ......"27518550Luciferase
hsa-miR-125b-5p

sarcomaprogression"miR 125b suppresses the proliferation and migratio ......"22093834
hsa-miR-125b-5p

sarcomadrug resistance"miR 125b develops chemoresistance in Ewing sarcoma ......"23497288
hsa-miR-125b-5p

sarcomaprogression; tumorigenesis"MiR 125b inhibits cell biological progression of E ......"24517182Western blot
hsa-miR-125b-5p

sarcomametastasis; progression; worse prognosis; staging; poor survival"Upregulation of miR 300 and downregulation of miR ......"26330295
hsa-miR-125b-5p

sarcomaprogression; drug resistance"Circulating miR 125b as a biomarker of Ewing's sar ......"26782555
hsa-miR-125b-5p

thyroid cancermalignant trasformation"A miRNA array was used to identify differentially ......"22006248



Reported gene related to hsa-miR-125b-5p

miRNAcancergenereportingPUBMED
hsa-miR-125b-5p

breast cancerTP53"The carboxy terminal domain of connexin 43 CT Cx4 ......"26335100
hsa-miR-125b-5p

cervical and endocervical cancerTP53"miR-34a is directly regulated by p53 and acts as t ......"24402874
hsa-miR-125b-5p

colorectal cancerTP53"In vitro assays revealed that overexpression of mi ......"21399871
hsa-miR-125b-5p

gastric cancerTP53"The results revealed that hsa-miR-125b may regulat ......"24846940
hsa-miR-125b-5p

glioblastomaTP53"MiR 125b acts as an oncogene in glioblastoma cells ......"24169356
hsa-miR-125b-5p

liver cancerTP53"Furthermore treatment of HCC cells with 5-aza-2'-d ......"23079745
hsa-miR-125b-5p

lung cancerTP53"In this study we have investigated the delivery an ......"26686386
hsa-miR-125b-5p

melanomaTP53"A stable overexpression of miR-125b in human melan ......"24762088
hsa-miR-125b-5p

pancreatic cancerTP53"TP53 and hsa-miR-125b were observed to form a self ......"24137477
hsa-miR-125b-5p

prostate cancerTP53"In this study we further extend our studies by sho ......"23585871
hsa-miR-125b-5p

breast cancerBAK1"We subsequently evaluated the effect of miR-125b-1 ......"27386402
hsa-miR-125b-5p

breast cancerBAK1"Moreover we demonstrated that the pro-apoptotic Bc ......"20460378
hsa-miR-125b-5p

cervical and endocervical cancerBAK1"In contrast miR-125b sponge impaired the anti-apop ......"23928699
hsa-miR-125b-5p

glioblastomaBAK1"miR 125b inhibitor enhance the chemosensitivity of ......"24643683
hsa-miR-125b-5p

ovarian cancerBAK1"An in vitro cytotoxicity assay and apoptosis assay ......"21823019
hsa-miR-125b-5p

prostate cancerBAK1"In addition transfection of synthetic miR-125b sti ......"18056640
hsa-miR-125b-5p

breast cancerERBB2"The noncoding RNA miR-125b has been described to r ......"19825990
hsa-miR-125b-5p

breast cancerERBB2"Due to the heterogeneity of breast cancers MCF7 ce ......"22307404
hsa-miR-125b-5p

endometrial cancerERBB2"RNA interference technology was used to confirm th ......"22460089
hsa-miR-125b-5p

prostate cancerERBB2"Relevant luciferase+3'-UTR expression studies conf ......"26544868
hsa-miR-125b-5p

sarcomaERBB2"miR 125b acts as a tumor suppressor in chondrosarc ......"26966351
hsa-miR-125b-5p

breast cancerBCL2"Moreover we demonstrated that the pro-apoptotic Bc ......"20460378
hsa-miR-125b-5p

glioblastomaBCL2"Moreover we demonstrated that the pro-apoptotic Bc ......"24643683
hsa-miR-125b-5p

ovarian cancerBCL2"miR 125b confers resistance of ovarian cancer cell ......"21823019
hsa-miR-125b-5p

sarcomaBCL2"Our data also verified that Bcl-2 is the target of ......"26744308
hsa-miR-125b-5p

liver cancerAFP"Combination of miR 125b and miR 27a enhances sensi ......"26637228
hsa-miR-125b-5p

liver cancerAFP"Multivariate analysis revealed that miR-125b tumor ......"27267832
hsa-miR-125b-5p

liver cancerAFP"miR-125b expression was also negatively correlated ......"24811246
hsa-miR-125b-5p

breast cancerMCL1"However the overexpression of miR-125b did not inf ......"25894378
hsa-miR-125b-5p

gastric cancerMCL1"miR 125b Suppresses Proliferation and Invasion by ......"26504803
hsa-miR-125b-5p

liver cancerMCL1"The ectopic expression of miR-125b reduced the cel ......"22942733
hsa-miR-125b-5p

bladder cancerSIRT7"Hsa miR 125b suppresses bladder cancer development ......"24512851
hsa-miR-125b-5p

bladder cancerSIRT7"Hsa miR 125b suppresses bladder cancer development ......"24396870
hsa-miR-125b-5p

liver cancerSIRT7"Four out of nine patients with induced SIRT7 carri ......"23079745
hsa-miR-125b-5p

ovarian cancerBCL3"MiR 125b targets BCL3 and suppresses ovarian cance ......"20658525
hsa-miR-125b-5p

ovarian cancerBCL3"In ovarian cancer miR-125b has been shown to be do ......"25944662
hsa-miR-125b-5p

breast cancerBMPR1B"A risk variant in an miR 125b binding site in BMPR ......"19738052
hsa-miR-125b-5p

prostate cancerBMPR1B"Our findings show that rs1434536 in the 3'UTR of B ......"21556765
hsa-miR-125b-5p

bladder cancerE2F3"E2F3 which was critical for G1/S transition and wa ......"20549700
hsa-miR-125b-5p

breast cancerE2F3"Moreover we demonstrated that the E2F3 was a direc ......"22523546
hsa-miR-125b-5p

ovarian cancerEIF4EBP1"Increased expression of miR-125a and miR-125b inhi ......"26646586
hsa-miR-125b-5p

prostate cancerEIF4EBP1"Using a bioinformatics approach we have identified ......"17891175
hsa-miR-125b-5p

breast cancerESR1"In this study we examined the global structural ch ......"20978686
hsa-miR-125b-5p

breast cancerESR1"Overexpression of the putative tumor suppressor mi ......"21375733
hsa-miR-125b-5p

colorectal cancerIBSP"We investigated the methylation status of miR-125 ......"26693202
hsa-miR-125b-5p

sarcomaIBSP"Bisulfite sequencing analysis BSP was used to dete ......"27576314
hsa-miR-125b-5p

bladder cancerMALAT1"Hsa miR 125b suppresses bladder cancer development ......"24512851
hsa-miR-125b-5p

bladder cancerMALAT1"Hsa miR 125b suppresses bladder cancer development ......"24396870
hsa-miR-125b-5p

bladder cancerMMP13"We also provided the first evidence that miR-125b ......"23425975
hsa-miR-125b-5p

lung squamous cell cancerMMP13"This study aimed to determine the relationship bet ......"25772251
hsa-miR-125b-5p

gastric cancerNEU1"STARD13 and NEU1 were identified as direct target ......"27220320
hsa-miR-125b-5p

pancreatic cancerNEU1"Thus far two of these target genes BBC3 and NEU1 t ......"25184537
hsa-miR-125b-5p

glioblastomaNOTCH1"Further research on the mechanism demonstrated tha ......"23835866
hsa-miR-125b-5p

liver cancerNOTCH1"Addition of GLPS to treat T cells inhibited Notch1 ......"25889022
hsa-miR-125b-5p

endometrial cancerNUPR1"In addition in vivo tumor formation assay confirme ......"21970405
hsa-miR-125b-5p

lung squamous cell cancerNUPR1"Further tumor protein 53-induced nuclear protein 1 ......"26388699
hsa-miR-125b-5p

bladder cancerPCNA"In addition we observed that transfection of miR-1 ......"20549700
hsa-miR-125b-5p

melanomaPCNA"Mel-Juso cells overexpressing miR-125b were tumour ......"24762088
hsa-miR-125b-5p

cervical and endocervical cancerPIK3CD"we identified phosphoinositide 3-kinase catalytic ......"23160634
hsa-miR-125b-5p

sarcomaPIK3CD"Further quantitative RT-PCR and western blot assay ......"24517182
hsa-miR-125b-5p

glioblastomaPROM1"Functional differences of miR 125b on the invasion ......"22711523
hsa-miR-125b-5p

glioblastomaPROM1"miR-125b as one of neuronal miRNAs is the most sig ......"22999819
hsa-miR-125b-5p

breast cancerSEMA4C"MiR 125b regulates epithelial mesenchymal transiti ......"25605244
hsa-miR-125b-5p

lung cancerSEMA4C"Moreover we found that miR-125b governed PR-induce ......"26351908
hsa-miR-125b-5p

breast cancerSTARD13"In addition it was implied STARD13 DLC2 was a dire ......"22693547
hsa-miR-125b-5p

gastric cancerSTARD13"STARD13 and NEU1 were identified as direct target ......"27220320
hsa-miR-125b-5p

sarcomaSTAT3"Dual-luciferase reporter assay was used to identif ......"27576314
hsa-miR-125b-5p

sarcomaSTAT3"miR 125b suppresses the proliferation and migratio ......"22093834
hsa-miR-125b-5p

endometrial cancerTP53INP1"MiR 125b promotes proliferation and migration of t ......"21970405
hsa-miR-125b-5p

lung squamous cell cancerTP53INP1"Expressions of miR-125b and TP53INP1 were detected ......"26388699
hsa-miR-125b-5p

breast cancerABCB1"The role of miR 125b mitochondria caspase 3 pathwa ......"25894378
hsa-miR-125b-5p

prostate cancerAGO2"Downregulation of AGO2 enhanced expression of miR- ......"24805183
hsa-miR-125b-5p

liver cancerANGPT2"Taken together our findings imply that miR-125b an ......"27577856
hsa-miR-125b-5p

breast cancerARID3B"miR 125b targets ARID3B in breast cancer cells; Am ......"22307404
hsa-miR-125b-5p

prostate cancerATP8A2"A miR 125b binding site polymorphism in bone morph ......"21556765
hsa-miR-125b-5p

pancreatic cancerBBC3"Thus far two of these target genes BBC3 and NEU1 t ......"25184537
hsa-miR-125b-5p

breast cancerCASP3"The role of miR 125b mitochondria caspase 3 pathwa ......"25894378
hsa-miR-125b-5p

bladder cancerCCNA2"In addition we observed that transfection of miR-1 ......"20549700
hsa-miR-125b-5p

melanomaCCND1"Mel-Juso cells overexpressing miR-125b were tumour ......"24762088
hsa-miR-125b-5p

prostate cancerCDKN2A"In this study we further extend our studies by sho ......"23585871
hsa-miR-125b-5p

cervical and endocervical cancerDLL1"MiR 125b inhibits tumor growth and promotes apopto ......"23160634
hsa-miR-125b-5p

breast cancerDYNLL2"In addition it was implied STARD13 DLC2 was a dire ......"22693547
hsa-miR-125b-5p

glioblastomaE2F2"miR 125b regulates the proliferation of glioblasto ......"22999819
hsa-miR-125b-5p

lung cancerEGFR"In a word Circulating 5 selected miRNAs may especi ......"26175938
hsa-miR-125b-5p

liver cancerEIF5A2"Among the 110 bioinformatically predicated candida ......"24811246
hsa-miR-125b-5p

breast cancerENPEP"The expression of ENPEP and CK2-α was inversely c ......"24098452
hsa-miR-125b-5p

breast cancerETS1"miR 125b is methylated and functions as a tumor su ......"21444677
hsa-miR-125b-5p

sarcomaEWSR1"We found miR-125b to be upregulated in two differe ......"23497288
hsa-miR-125b-5p

liver cancerFOXP3"Addition of GLPS to treat T cells inhibited Notch1 ......"25889022
hsa-miR-125b-5p

breast cancerGJA1"The carboxy terminal domain of connexin 43 CT Cx4 ......"26335100
hsa-miR-125b-5p

melanomaGLB1"A stable overexpression of miR-125b in human melan ......"24762088
hsa-miR-125b-5p

glioblastomaGLI1"Thirteen miRNAs including miR-125b-1 were downregu ......"24688313
hsa-miR-125b-5p

liver cancerHOTTIP"Long non coding RNA HOTTIP is frequently up regula ......"25424744
hsa-miR-125b-5p

liver cancerIL6R"The ectopic expression of miR-125b reduced the cel ......"22942733
hsa-miR-125b-5p

B cell lymphomaIRF4"We provide experimental evidence that these change ......"19047678
hsa-miR-125b-5p

melanomaJUN"MicroRNA miR 125b controls melanoma progression by ......"22797068
hsa-miR-125b-5p

lung squamous cell cancerKLC2"This study is to identify the function of KLC2 and ......"25668010
hsa-miR-125b-5p

glioblastomaLIN28A"miR 125b promotes cell proliferation by directly t ......"24356103
hsa-miR-125b-5p

liver cancerLIN28B"Silencing of LIN28B recapitulated the effects of m ......"20827722
hsa-miR-125b-5p

B cell lymphomaLMO2"We provide experimental evidence that these change ......"19047678
hsa-miR-125b-5p

head and neck cancerMAP2K6"We report that miR-125b-1 causes mitogen-activated ......"23416980
hsa-miR-125b-5p

breast cancerMAP2K7"miR 125b inhibited epithelial mesenchymal transiti ......"27226726
hsa-miR-125b-5p

melanomaMAP3K11"Expression of the miRNA miR-125b and serine/threon ......"24635082
hsa-miR-125b-5p

melanomaMARK2"Expression of the miRNA miR-125b and serine/threon ......"24635082
hsa-miR-125b-5p

glioblastomaMAZ"Here we report that miR-125b is down-regulated in ......"22415301
hsa-miR-125b-5p

prostate cancerMBD2"The histone demethylase PHF8 promotes prostate can ......"26309412
hsa-miR-125b-5p

prostate cancerMDM2"Conversely treatment of prostate cancer cells with ......"23585871
hsa-miR-125b-5p

breast cancerMEMO1"Overexpression of the putative tumor suppressor mi ......"21375733
hsa-miR-125b-5p

liver cancerMMP2"Furthermore modulation of miR-125b also distorted ......"21703189
hsa-miR-125b-5p

lung squamous cell cancerMTA1"MTA1 promotes the invasion and migration of non sm ......"23718732
hsa-miR-125b-5p

lymphomaMXD4"Bortezomib repressed cMyc and simultaneously induc ......"23527180
hsa-miR-125b-5p

lung squamous cell cancerMYL4"High expression of kinesin light chain 2 a novel t ......"25668010
hsa-miR-125b-5p

melanomaNEDD9"Furthermore we show that neural precursor cell exp ......"26968260
hsa-miR-125b-5p

glioblastomaNES"An inverse relationship between miR-125b and nesti ......"24817689
hsa-miR-125b-5p

glioblastomaNKIRAS2"miR 125b controls apoptosis and temozolomide resis ......"24901050
hsa-miR-125b-5p

lung cancerNPS"Systemic plasmid DNA delivery with dual CD44/EGFR- ......"26686386
hsa-miR-125b-5p

breast cancerNR4A1"There were no significant correlations between miR ......"26782438
hsa-miR-125b-5p

liver cancerPGF"Placenta growth factor was identified as a target ......"21703189
hsa-miR-125b-5p

prostate cancerPHF8"The histone demethylase PHF8 promotes prostate can ......"26309412
hsa-miR-125b-5p

glioblastomaPIAS3"miR 125b inhibitor may enhance the invasion preven ......"23857508
hsa-miR-125b-5p

liver cancerPIGF"Overexpression of miR-125b in HCC cells decreased ......"21703189
hsa-miR-125b-5p

prostate cancerPPFIA3"A miR 125b binding site polymorphism in bone morph ......"21556765
hsa-miR-125b-5p

gastric cancerPPP1CA"MiR 125b promotes cell migration and invasion by t ......"25240408
hsa-miR-125b-5p

melanomaPRDX2"Treatment with 5-Aza but not with TSA reduced the ......"22213330
hsa-miR-125b-5p

prostate cancerPTEN"Relevant luciferase+3'-UTR expression studies conf ......"26544868
hsa-miR-125b-5p

breast cancerRAF1"A short hairpin DNA analogous to miR 125b inhibits ......"19825990
hsa-miR-125b-5p

lung squamous cell cancerSCLC1"Cisplatin CDDP treatment of SCLC cells resulted in ......"25833836
hsa-miR-125b-5p

liver cancerSMAD2"Mechanistically our data revealed that miR-125b su ......"25953743
hsa-miR-125b-5p

bladder cancerSPHK1"Overexpression of miR-125b inhibited cellular grow ......"26807182
hsa-miR-125b-5p

liver cancerSUV39H1"We also identified microRNA-125b miR-125b as a pos ......"22991213
hsa-miR-125b-5p

head and neck cancerTACSTD2"Loss of miR 125b 1 contributes to head and neck ca ......"23416980
hsa-miR-125b-5p

melanomaTCF4"Also transcription factor 4 associated with epithe ......"26968260
hsa-miR-125b-5p

glioblastomaTNFAIP3"miR 125b controls apoptosis and temozolomide resis ......"24901050
hsa-miR-125b-5p

lymphomaTSPYL2"Using cutaneous T-cell lymphoma CTCL as a model of ......"23527180
hsa-miR-125b-5p

breast cancerTSTA3"miR-125a-5p and miR-125b are upstream targets of T ......"26531722
hsa-miR-125b-5p

melanomaVDR"The expression of VDR mRNA protein and two candida ......"22213330
hsa-miR-125b-5p

glioblastomaVEGFA"Here we report that miR-125b is down-regulated in ......"22415301



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-125b-5p
ACLY
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.064; TCGA BRCA -0.139; TCGA CESC -0.134; TCGA COAD -0.053; TCGA ESCA -0.154; TCGA HNSC -0.234; TCGA KIRC -0.467; TCGA KIRP -0.146; TCGA LGG -0.1; TCGA LIHC -0.274; TCGA LUAD -0.086; TCGA LUSC -0.184; TCGA THCA -0.177; TCGA STAD -0.083; TCGA UCEC -0.064
hsa-miR-125b-5p
ADRM1
9 cancers: BLCA; BRCA; ESCA; HNSC; LIHC; LUSC; OV; PAAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.052; TCGA BRCA -0.271; TCGA ESCA -0.118; TCGA HNSC -0.104; TCGA LIHC -0.062; TCGA LUSC -0.148; TCGA OV -0.158; TCGA PAAD -0.317; TCGA UCEC -0.116
hsa-miR-125b-5p
AKT1
10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUSC; OV; PAAD; SARC
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.075; TCGA BRCA -0.198; TCGA CESC -0.054; TCGA COAD -0.056; TCGA HNSC -0.076; TCGA LGG -0.071; TCGA LUSC -0.1; TCGA OV -0.077; TCGA PAAD -0.115; TCGA SARC -0.093
hsa-miR-125b-5p
ARID3B
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; SARC; THCA; UCEC
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BLCA -0.135; TCGA BRCA -0.115; TCGA CESC -0.11; TCGA COAD -0.06; TCGA ESCA -0.26; TCGA HNSC -0.103; TCGA KIRC -0.157; TCGA KIRP -0.093; TCGA LIHC -0.19; TCGA LUSC -0.135; TCGA PRAD -0.076; TCGA SARC -0.132; TCGA THCA -0.088; TCGA UCEC -0.068
hsa-miR-125b-5p
ATP5B
13 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.069; TCGA BRCA -0.099; TCGA COAD -0.173; TCGA ESCA -0.16; TCGA LGG -0.097; TCGA LUAD -0.104; TCGA LUSC -0.168; TCGA OV -0.08; TCGA PAAD -0.144; TCGA PRAD -0.108; TCGA THCA -0.347; TCGA STAD -0.194; TCGA UCEC -0.066
hsa-miR-125b-5p
BAK1
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate; miRTarBase; miRNATAP
TCGA BLCA -0.102; TCGA BRCA -0.174; TCGA CESC -0.145; TCGA COAD -0.198; TCGA ESCA -0.263; TCGA HNSC -0.336; TCGA LGG -0.095; TCGA LIHC -0.401; TCGA LUAD -0.06; TCGA LUSC -0.188; TCGA OV -0.198; TCGA PAAD -0.169; TCGA PRAD -0.108; TCGA THCA -0.201; TCGA STAD -0.119; TCGA UCEC -0.203
hsa-miR-125b-5p
CBFB
10 cancers: BLCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; PRAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase; miRNATAP
TCGA BLCA -0.058; TCGA HNSC -0.084; TCGA KIRC -0.145; TCGA KIRP -0.139; TCGA LGG -0.117; TCGA LIHC -0.115; TCGA LUAD -0.073; TCGA PRAD -0.155; TCGA STAD -0.154; TCGA UCEC -0.063
hsa-miR-125b-5p
CEBPG
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.077; TCGA BRCA -0.065; TCGA CESC -0.062; TCGA COAD -0.085; TCGA ESCA -0.23; TCGA HNSC -0.092; TCGA KIRC -0.085; TCGA KIRP -0.059; TCGA LIHC -0.072; TCGA LUAD -0.138; TCGA LUSC -0.261; TCGA OV -0.078; TCGA SARC -0.156; TCGA THCA -0.336; TCGA STAD -0.148; TCGA UCEC -0.068
hsa-miR-125b-5p
COX7C
9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; LUSC; PAAD
miRNAWalker2 validate
TCGA BLCA -0.108; TCGA BRCA -0.121; TCGA COAD -0.073; TCGA ESCA -0.112; TCGA LGG -0.059; TCGA LIHC -0.066; TCGA LUAD -0.071; TCGA LUSC -0.141; TCGA PAAD -0.186
hsa-miR-125b-5p
DGAT1
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LIHC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.128; TCGA BRCA -0.131; TCGA CESC -0.106; TCGA COAD -0.162; TCGA ESCA -0.386; TCGA LGG -0.184; TCGA LIHC -0.084; TCGA OV -0.186; TCGA PAAD -0.377; TCGA STAD -0.161; TCGA UCEC -0.107
hsa-miR-125b-5p
E2F3
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase; miRNATAP
TCGA BLCA -0.143; TCGA BRCA -0.091; TCGA CESC -0.119; TCGA COAD -0.054; TCGA ESCA -0.087; TCGA KIRP -0.103; TCGA LGG -0.095; TCGA LIHC -0.3; TCGA LUAD -0.119; TCGA LUSC -0.202; TCGA PRAD -0.239; TCGA STAD -0.147; TCGA UCEC -0.07
hsa-miR-125b-5p
E2F7
13 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.179; TCGA BRCA -0.515; TCGA COAD -0.207; TCGA HNSC -0.174; TCGA KIRC -0.672; TCGA KIRP -0.525; TCGA LGG -0.332; TCGA LIHC -0.644; TCGA LUSC -0.466; TCGA PRAD -0.248; TCGA SARC -0.405; TCGA STAD -0.465; TCGA UCEC -0.116
hsa-miR-125b-5p
EIF5
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PRAD; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.101; TCGA CESC -0.064; TCGA COAD -0.116; TCGA ESCA -0.094; TCGA HNSC -0.122; TCGA LUSC -0.143; TCGA OV -0.074; TCGA PRAD -0.142; TCGA THCA -0.09; TCGA STAD -0.11
hsa-miR-125b-5p
ERBB3
9 cancers: BLCA; BRCA; CESC; ESCA; KIRC; LIHC; LUAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.376; TCGA BRCA -0.246; TCGA CESC -0.139; TCGA ESCA -0.543; TCGA KIRC -0.397; TCGA LIHC -0.261; TCGA LUAD -0.277; TCGA STAD -0.253; TCGA UCEC -0.285
hsa-miR-125b-5p
ESRP2
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.199; TCGA BRCA -0.227; TCGA CESC -0.098; TCGA COAD -0.097; TCGA ESCA -0.168; TCGA HNSC -0.157; TCGA LUAD -0.128; TCGA LUSC -0.223; TCGA PAAD -0.168; TCGA STAD -0.27; TCGA UCEC -0.114
hsa-miR-125b-5p
FAM199X
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.133; TCGA BRCA -0.084; TCGA CESC -0.062; TCGA COAD -0.083; TCGA ESCA -0.133; TCGA HNSC -0.177; TCGA LIHC -0.127; TCGA LUAD -0.14; TCGA LUSC -0.178; TCGA OV -0.124; TCGA PRAD -0.217; TCGA SARC -0.131; TCGA THCA -0.229; TCGA STAD -0.176; TCGA UCEC -0.138
hsa-miR-125b-5p
FAM60A
9 cancers: BLCA; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.169; TCGA COAD -0.082; TCGA KIRP -0.087; TCGA LGG -0.171; TCGA LIHC -0.327; TCGA LUAD -0.226; TCGA LUSC -0.15; TCGA PRAD -0.191; TCGA STAD -0.21
hsa-miR-125b-5p
FAM91A1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.051; TCGA BRCA -0.107; TCGA CESC -0.079; TCGA COAD -0.084; TCGA ESCA -0.236; TCGA HNSC -0.207; TCGA LIHC -0.076; TCGA LUAD -0.169; TCGA LUSC -0.124; TCGA OV -0.165; TCGA PRAD -0.167; TCGA THCA -0.05; TCGA STAD -0.241; TCGA UCEC -0.055
hsa-miR-125b-5p
FBXL20
9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LUAD; LUSC; OV; PRAD
miRNAWalker2 validate
TCGA BLCA -0.107; TCGA BRCA -0.06; TCGA CESC -0.069; TCGA HNSC -0.11; TCGA KIRC -0.066; TCGA LUAD -0.17; TCGA LUSC -0.188; TCGA OV -0.08; TCGA PRAD -0.143
hsa-miR-125b-5p
FRAT2
11 cancers: BLCA; BRCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate; miRNATAP
TCGA BLCA -0.14; TCGA BRCA -0.211; TCGA ESCA -0.245; TCGA KIRP -0.088; TCGA LGG -0.094; TCGA LIHC -0.192; TCGA LUAD -0.094; TCGA LUSC -0.264; TCGA PAAD -0.212; TCGA STAD -0.19; TCGA UCEC -0.121
hsa-miR-125b-5p
HK2
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.221; TCGA BRCA -0.162; TCGA CESC -0.257; TCGA COAD -0.25; TCGA ESCA -0.241; TCGA HNSC -0.38; TCGA KIRC -1.044; TCGA KIRP -0.503; TCGA LIHC -0.451; TCGA LUSC -0.288; TCGA STAD -0.438; TCGA UCEC -0.131
hsa-miR-125b-5p
HSPD1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.073; TCGA BRCA -0.173; TCGA CESC -0.183; TCGA COAD -0.125; TCGA ESCA -0.223; TCGA HNSC -0.145; TCGA LIHC -0.198; TCGA LUAD -0.218; TCGA LUSC -0.321; TCGA PAAD -0.191; TCGA PRAD -0.171; TCGA THCA -0.111; TCGA STAD -0.312; TCGA UCEC -0.137
hsa-miR-125b-5p
KIF24
11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUSC; PAAD; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.082; TCGA BRCA -0.283; TCGA COAD -0.124; TCGA ESCA -0.195; TCGA KIRP -0.102; TCGA LIHC -0.359; TCGA LUSC -0.213; TCGA PAAD -0.23; TCGA SARC -0.184; TCGA THCA -0.064; TCGA STAD -0.252
hsa-miR-125b-5p
LTV1
11 cancers: BLCA; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.06; TCGA COAD -0.075; TCGA ESCA -0.129; TCGA KIRP -0.059; TCGA LIHC -0.109; TCGA LUAD -0.074; TCGA LUSC -0.137; TCGA PRAD -0.179; TCGA THCA -0.061; TCGA STAD -0.143; TCGA UCEC -0.055
hsa-miR-125b-5p
MED1
9 cancers: BLCA; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.075; TCGA ESCA -0.108; TCGA HNSC -0.062; TCGA LIHC -0.05; TCGA LUAD -0.086; TCGA LUSC -0.125; TCGA PRAD -0.097; TCGA THCA -0.141; TCGA STAD -0.086
hsa-miR-125b-5p
MTMR4
11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.146; TCGA BRCA -0.108; TCGA COAD -0.104; TCGA ESCA -0.075; TCGA LUAD -0.126; TCGA LUSC -0.092; TCGA PAAD -0.103; TCGA PRAD -0.073; TCGA SARC -0.071; TCGA THCA -0.271; TCGA STAD -0.141
hsa-miR-125b-5p
MYO19
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.12; TCGA BRCA -0.267; TCGA CESC -0.084; TCGA COAD -0.164; TCGA ESCA -0.173; TCGA HNSC -0.116; TCGA LGG -0.157; TCGA LIHC -0.335; TCGA LUAD -0.185; TCGA LUSC -0.384; TCGA PAAD -0.269; TCGA PRAD -0.14; TCGA SARC -0.221; TCGA THCA -0.151; TCGA STAD -0.268; TCGA UCEC -0.126
hsa-miR-125b-5p
NDOR1
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.069; TCGA BRCA -0.291; TCGA CESC -0.078; TCGA COAD -0.077; TCGA ESCA -0.217; TCGA HNSC -0.075; TCGA LGG -0.091; TCGA LIHC -0.269; TCGA LUSC -0.235; TCGA OV -0.067; TCGA PAAD -0.354; TCGA STAD -0.201; TCGA UCEC -0.086
hsa-miR-125b-5p
NKIRAS2
10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; THCA
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.059; TCGA BRCA -0.097; TCGA HNSC -0.071; TCGA KIRC -0.103; TCGA LGG -0.182; TCGA LIHC -0.113; TCGA LUAD -0.086; TCGA LUSC -0.18; TCGA PAAD -0.089; TCGA THCA -0.112
hsa-miR-125b-5p
NME2
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.079; TCGA BRCA -0.197; TCGA CESC -0.123; TCGA COAD -0.084; TCGA ESCA -0.148; TCGA HNSC -0.157; TCGA KIRP -0.125; TCGA LIHC -0.281; TCGA LUAD -0.154; TCGA LUSC -0.338; TCGA OV -0.119; TCGA PAAD -0.221; TCGA UCEC -0.085
hsa-miR-125b-5p
NPM1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.054; TCGA BRCA -0.074; TCGA CESC -0.068; TCGA COAD -0.111; TCGA ESCA -0.09; TCGA HNSC -0.146; TCGA KIRC -0.138; TCGA KIRP -0.107; TCGA LGG -0.189; TCGA LIHC -0.319; TCGA LUAD -0.064; TCGA LUSC -0.116; TCGA PRAD -0.096; TCGA STAD -0.19
hsa-miR-125b-5p
NSUN2
16 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.06; TCGA BRCA -0.115; TCGA CESC -0.128; TCGA COAD -0.079; TCGA HNSC -0.144; TCGA KIRP -0.058; TCGA LGG -0.1; TCGA LUAD -0.134; TCGA LUSC -0.13; TCGA OV -0.065; TCGA PAAD -0.187; TCGA PRAD -0.11; TCGA SARC -0.077; TCGA THCA -0.069; TCGA STAD -0.217; TCGA UCEC -0.051
hsa-miR-125b-5p
NUP205
9 cancers: BLCA; BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.053; TCGA BRCA -0.081; TCGA COAD -0.098; TCGA HNSC -0.119; TCGA LIHC -0.2; TCGA LUAD -0.122; TCGA LUSC -0.282; TCGA PRAD -0.119; TCGA STAD -0.191
hsa-miR-125b-5p
PABPC1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.135; TCGA BRCA -0.058; TCGA CESC -0.162; TCGA COAD -0.082; TCGA ESCA -0.12; TCGA HNSC -0.128; TCGA KIRC -0.102; TCGA KIRP -0.146; TCGA LGG -0.233; TCGA LIHC -0.353; TCGA LUAD -0.152; TCGA LUSC -0.122; TCGA PRAD -0.164; TCGA STAD -0.197
hsa-miR-125b-5p
PDZD11
10 cancers: BLCA; BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.075; TCGA BRCA -0.169; TCGA HNSC -0.083; TCGA LGG -0.072; TCGA LIHC -0.211; TCGA LUAD -0.113; TCGA LUSC -0.188; TCGA OV -0.194; TCGA PAAD -0.169; TCGA UCEC -0.064
hsa-miR-125b-5p
PIGF
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.067; TCGA BRCA -0.105; TCGA CESC -0.102; TCGA COAD -0.108; TCGA ESCA -0.178; TCGA KIRP -0.067; TCGA LGG -0.053; TCGA LIHC -0.088; TCGA LUAD -0.138; TCGA LUSC -0.182; TCGA PRAD -0.091; TCGA STAD -0.057
hsa-miR-125b-5p
PIP4K2C
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.069; TCGA BRCA -0.181; TCGA CESC -0.08; TCGA COAD -0.052; TCGA ESCA -0.117; TCGA HNSC -0.155; TCGA LUAD -0.059; TCGA LUSC -0.128; TCGA THCA -0.193; TCGA STAD -0.111
hsa-miR-125b-5p
PPAT
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BLCA -0.072; TCGA BRCA -0.184; TCGA CESC -0.086; TCGA COAD -0.128; TCGA ESCA -0.145; TCGA HNSC -0.135; TCGA KIRP -0.096; TCGA LIHC -0.203; TCGA LUAD -0.211; TCGA LUSC -0.222; TCGA OV -0.08; TCGA PRAD -0.251; TCGA THCA -0.145; TCGA STAD -0.276; TCGA UCEC -0.082
hsa-miR-125b-5p
RPLP0
13 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.072; TCGA CESC -0.076; TCGA COAD -0.09; TCGA ESCA -0.106; TCGA KIRC -0.166; TCGA KIRP -0.158; TCGA LGG -0.175; TCGA LIHC -0.273; TCGA LUAD -0.115; TCGA LUSC -0.115; TCGA PAAD -0.301; TCGA PRAD -0.086; TCGA STAD -0.138
hsa-miR-125b-5p
RPS6KA1
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; OV; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BLCA -0.137; TCGA BRCA -0.138; TCGA CESC -0.077; TCGA COAD -0.105; TCGA ESCA -0.235; TCGA HNSC -0.154; TCGA OV -0.126; TCGA PRAD -0.062; TCGA THCA -0.186; TCGA STAD -0.225; TCGA UCEC -0.217
hsa-miR-125b-5p
RPS7
11 cancers: BLCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.081; TCGA CESC -0.071; TCGA HNSC -0.074; TCGA KIRP -0.078; TCGA LGG -0.068; TCGA LIHC -0.284; TCGA LUAD -0.145; TCGA LUSC -0.21; TCGA PAAD -0.223; TCGA PRAD -0.142; TCGA STAD -0.084
hsa-miR-125b-5p
SAMD10
10 cancers: BLCA; BRCA; KIRP; LGG; LIHC; LUAD; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BLCA -0.221; TCGA BRCA -0.297; TCGA KIRP -0.106; TCGA LGG -0.265; TCGA LIHC -0.302; TCGA LUAD -0.111; TCGA PAAD -0.433; TCGA SARC -0.19; TCGA STAD -0.181; TCGA UCEC -0.125
hsa-miR-125b-5p
SDHB
12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.062; TCGA BRCA -0.095; TCGA COAD -0.131; TCGA ESCA -0.158; TCGA HNSC -0.051; TCGA LUAD -0.068; TCGA LUSC -0.104; TCGA OV -0.166; TCGA PRAD -0.122; TCGA THCA -0.139; TCGA STAD -0.106; TCGA UCEC -0.141
hsa-miR-125b-5p
SLC19A1
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.129; TCGA BRCA -0.314; TCGA CESC -0.242; TCGA COAD -0.112; TCGA ESCA -0.271; TCGA HNSC -0.16; TCGA LGG -0.168; TCGA PAAD -0.307; TCGA THCA -0.302; TCGA STAD -0.222; TCGA UCEC -0.08
hsa-miR-125b-5p
SLC25A1
13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.13; TCGA BRCA -0.106; TCGA CESC -0.065; TCGA COAD -0.087; TCGA HNSC -0.095; TCGA LGG -0.225; TCGA LUSC -0.2; TCGA OV -0.121; TCGA PAAD -0.261; TCGA SARC -0.091; TCGA THCA -0.079; TCGA STAD -0.1; TCGA UCEC -0.125
hsa-miR-125b-5p
SMARCD2
13 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate; miRNATAP
TCGA BLCA -0.066; TCGA BRCA -0.133; TCGA COAD -0.081; TCGA ESCA -0.114; TCGA KIRP -0.148; TCGA LUAD -0.088; TCGA LUSC -0.164; TCGA OV -0.108; TCGA PAAD -0.13; TCGA PRAD -0.063; TCGA THCA -0.1; TCGA STAD -0.126; TCGA UCEC -0.052
hsa-miR-125b-5p
SNRPB
13 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.066; TCGA BRCA -0.326; TCGA ESCA -0.137; TCGA HNSC -0.164; TCGA KIRP -0.102; TCGA LGG -0.094; TCGA LIHC -0.357; TCGA LUAD -0.141; TCGA LUSC -0.224; TCGA OV -0.115; TCGA PAAD -0.346; TCGA STAD -0.139; TCGA UCEC -0.137
hsa-miR-125b-5p
STRN3
9 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; SARC; THCA
miRNAWalker2 validate
TCGA BLCA -0.06; TCGA CESC -0.062; TCGA COAD -0.123; TCGA HNSC -0.226; TCGA LUAD -0.126; TCGA LUSC -0.141; TCGA PRAD -0.118; TCGA SARC -0.129; TCGA THCA -0.07
hsa-miR-125b-5p
TDG
14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD; UCEC
miRNAWalker2 validate; miRNATAP
TCGA BLCA -0.141; TCGA BRCA -0.065; TCGA CESC -0.077; TCGA COAD -0.115; TCGA HNSC -0.175; TCGA KIRC -0.12; TCGA KIRP -0.09; TCGA LGG -0.134; TCGA LIHC -0.201; TCGA LUAD -0.264; TCGA LUSC -0.213; TCGA PRAD -0.249; TCGA STAD -0.197; TCGA UCEC -0.069
hsa-miR-125b-5p
THUMPD3
11 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.074; TCGA BRCA -0.09; TCGA COAD -0.102; TCGA ESCA -0.073; TCGA LIHC -0.084; TCGA LUAD -0.086; TCGA LUSC -0.158; TCGA PRAD -0.065; TCGA SARC -0.097; TCGA STAD -0.107; TCGA UCEC -0.068
hsa-miR-125b-5p
UBA6
9 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BLCA -0.144; TCGA COAD -0.115; TCGA HNSC -0.245; TCGA KIRC -0.084; TCGA KIRP -0.066; TCGA LUAD -0.058; TCGA LUSC -0.154; TCGA PRAD -0.076; TCGA STAD -0.227
hsa-miR-125b-5p
ULK3
9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUSC; PRAD; SARC; STAD
miRNAWalker2 validate
TCGA BLCA -0.135; TCGA BRCA -0.241; TCGA COAD -0.075; TCGA ESCA -0.098; TCGA KIRC -0.106; TCGA LUSC -0.165; TCGA PRAD -0.08; TCGA SARC -0.129; TCGA STAD -0.079
hsa-miR-125b-5p
UNG
10 cancers: BLCA; BRCA; COAD; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD
miRNAWalker2 validate
TCGA BLCA -0.079; TCGA BRCA -0.158; TCGA COAD -0.111; TCGA LIHC -0.09; TCGA LUAD -0.158; TCGA LUSC -0.247; TCGA PAAD -0.133; TCGA PRAD -0.153; TCGA THCA -0.126; TCGA STAD -0.165
hsa-miR-125b-5p
VDAC1
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BLCA -0.11; TCGA BRCA -0.149; TCGA CESC -0.122; TCGA COAD -0.074; TCGA ESCA -0.277; TCGA HNSC -0.095; TCGA LIHC -0.194; TCGA LUAD -0.116; TCGA LUSC -0.154; TCGA OV -0.105; TCGA PAAD -0.131; TCGA PRAD -0.09; TCGA THCA -0.077; TCGA STAD -0.164; TCGA UCEC -0.134
hsa-miR-125b-5p
ZDHHC5
9 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRP; LUSC; OV; STAD
miRNAWalker2 validate
TCGA BLCA -0.093; TCGA BRCA -0.05; TCGA COAD -0.081; TCGA ESCA -0.072; TCGA HNSC -0.127; TCGA KIRP -0.094; TCGA LUSC -0.095; TCGA OV -0.058; TCGA STAD -0.101
hsa-miR-125b-5p
PPP1CA
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRTarBase
TCGA BLCA -0.08; TCGA BRCA -0.295; TCGA CESC -0.076; TCGA COAD -0.102; TCGA ESCA -0.128; TCGA HNSC -0.172; TCGA KIRP -0.058; TCGA LIHC -0.112; TCGA LUAD -0.073; TCGA LUSC -0.098; TCGA OV -0.203; TCGA PAAD -0.197; TCGA STAD -0.115; TCGA UCEC -0.14
hsa-miR-125b-5p
PRRC1
10 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; LUAD; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.067; TCGA BRCA -0.052; TCGA COAD -0.07; TCGA ESCA -0.128; TCGA LGG -0.128; TCGA LIHC -0.088; TCGA LUAD -0.103; TCGA PRAD -0.161; TCGA THCA -0.08; TCGA STAD -0.15
hsa-miR-125b-5p
ZSCAN29
11 cancers: BLCA; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PRAD; SARC; STAD
MirTarget; miRNATAP
TCGA BLCA -0.152; TCGA ESCA -0.149; TCGA HNSC -0.06; TCGA KIRC -0.134; TCGA LGG -0.072; TCGA LIHC -0.068; TCGA LUAD -0.125; TCGA LUSC -0.155; TCGA PRAD -0.11; TCGA SARC -0.055; TCGA STAD -0.086
hsa-miR-125b-5p
MMP15
11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.2; TCGA BRCA -0.077; TCGA CESC -0.255; TCGA COAD -0.1; TCGA ESCA -0.426; TCGA LGG -0.412; TCGA LUSC -0.21; TCGA PRAD -0.157; TCGA THCA -0.344; TCGA STAD -0.191; TCGA UCEC -0.185
hsa-miR-125b-5p
SUV39H1
15 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.067; TCGA BRCA -0.181; TCGA COAD -0.089; TCGA ESCA -0.115; TCGA KIRC -0.098; TCGA LGG -0.157; TCGA LIHC -0.13; TCGA LUAD -0.111; TCGA LUSC -0.276; TCGA OV -0.158; TCGA PAAD -0.238; TCGA SARC -0.195; TCGA THCA -0.055; TCGA STAD -0.142; TCGA UCEC -0.079
hsa-miR-125b-5p
PPIF
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.099; TCGA BRCA -0.179; TCGA CESC -0.085; TCGA COAD -0.1; TCGA ESCA -0.171; TCGA HNSC -0.391; TCGA LGG -0.22; TCGA LUAD -0.145; TCGA LUSC -0.31; TCGA OV -0.18; TCGA PAAD -0.295; TCGA PRAD -0.106; TCGA THCA -0.495; TCGA STAD -0.22; TCGA UCEC -0.171
hsa-miR-125b-5p
DRAM2
11 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; OV; SARC; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.067; TCGA CESC -0.055; TCGA COAD -0.056; TCGA ESCA -0.124; TCGA KIRC -0.068; TCGA LIHC -0.148; TCGA LUAD -0.071; TCGA OV -0.159; TCGA SARC -0.099; TCGA THCA -0.131; TCGA UCEC -0.108
hsa-miR-125b-5p
NUP210
12 cancers: BLCA; BRCA; CESC; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.121; TCGA BRCA -0.466; TCGA CESC -0.087; TCGA LGG -0.235; TCGA LIHC -0.373; TCGA LUAD -0.261; TCGA LUSC -0.258; TCGA OV -0.194; TCGA PRAD -0.36; TCGA SARC -0.536; TCGA THCA -0.292; TCGA UCEC -0.219
hsa-miR-125b-5p
RFC5
12 cancers: BLCA; BRCA; COAD; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
MirTarget
TCGA BLCA -0.105; TCGA BRCA -0.171; TCGA COAD -0.166; TCGA KIRP -0.135; TCGA LIHC -0.183; TCGA LUAD -0.208; TCGA LUSC -0.268; TCGA PAAD -0.173; TCGA PRAD -0.159; TCGA SARC -0.078; TCGA THCA -0.118; TCGA STAD -0.207
hsa-miR-125b-5p
OVOL1
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.442; TCGA BRCA -0.359; TCGA CESC -0.199; TCGA COAD -0.096; TCGA ESCA -0.439; TCGA HNSC -0.466; TCGA LUAD -0.204; TCGA LUSC -0.531; TCGA OV -0.294; TCGA PRAD -0.363; TCGA STAD -0.305; TCGA UCEC -0.291
hsa-miR-125b-5p
CSNK2A1
11 cancers: BLCA; BRCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.052; TCGA BRCA -0.069; TCGA ESCA -0.144; TCGA HNSC -0.074; TCGA LGG -0.087; TCGA LIHC -0.149; TCGA LUAD -0.08; TCGA LUSC -0.096; TCGA PRAD -0.169; TCGA THCA -0.102; TCGA STAD -0.128
hsa-miR-125b-5p
DUS1L
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.147; TCGA BRCA -0.297; TCGA CESC -0.143; TCGA COAD -0.08; TCGA ESCA -0.279; TCGA HNSC -0.12; TCGA KIRC -0.09; TCGA KIRP -0.086; TCGA LIHC -0.104; TCGA LUAD -0.13; TCGA LUSC -0.368; TCGA OV -0.175; TCGA PAAD -0.449; TCGA THCA -0.089; TCGA STAD -0.152; TCGA UCEC -0.217
hsa-miR-125b-5p
IER3IP1
12 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.06; TCGA BRCA -0.189; TCGA COAD -0.122; TCGA LGG -0.105; TCGA LIHC -0.133; TCGA LUAD -0.189; TCGA LUSC -0.197; TCGA OV -0.166; TCGA PAAD -0.118; TCGA PRAD -0.101; TCGA STAD -0.157; TCGA UCEC -0.123
hsa-miR-125b-5p
SIRT7
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC
MirTarget
TCGA BLCA -0.118; TCGA BRCA -0.281; TCGA CESC -0.101; TCGA COAD -0.106; TCGA ESCA -0.248; TCGA HNSC -0.123; TCGA KIRC -0.158; TCGA KIRP -0.158; TCGA LGG -0.108; TCGA LIHC -0.218; TCGA LUSC -0.311; TCGA OV -0.138; TCGA PAAD -0.313; TCGA STAD -0.142; TCGA UCEC -0.15
hsa-miR-125b-5p
TSEN54
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
MirTarget
TCGA BLCA -0.087; TCGA BRCA -0.353; TCGA CESC -0.09; TCGA COAD -0.113; TCGA ESCA -0.255; TCGA HNSC -0.079; TCGA KIRP -0.09; TCGA LGG -0.169; TCGA LIHC -0.305; TCGA LUAD -0.147; TCGA LUSC -0.31; TCGA OV -0.128; TCGA PAAD -0.389; TCGA STAD -0.16; TCGA UCEC -0.112
hsa-miR-125b-5p
BDH1
13 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.167; TCGA BRCA -0.317; TCGA COAD -0.125; TCGA ESCA -0.245; TCGA HNSC -0.164; TCGA LUAD -0.168; TCGA LUSC -0.472; TCGA OV -0.147; TCGA PAAD -0.302; TCGA SARC -0.512; TCGA THCA -0.294; TCGA STAD -0.261; TCGA UCEC -0.152
hsa-miR-125b-5p
LRRC8B
9 cancers: BLCA; COAD; ESCA; LUAD; PRAD; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.114; TCGA COAD -0.112; TCGA ESCA -0.138; TCGA LUAD -0.136; TCGA PRAD -0.255; TCGA SARC -0.305; TCGA THCA -0.073; TCGA STAD -0.272; TCGA UCEC -0.085
hsa-miR-125b-5p
DLD
11 cancers: BLCA; COAD; ESCA; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.053; TCGA COAD -0.092; TCGA ESCA -0.077; TCGA LUAD -0.064; TCGA LUSC -0.114; TCGA OV -0.062; TCGA PRAD -0.075; TCGA SARC -0.055; TCGA THCA -0.348; TCGA STAD -0.15; TCGA UCEC -0.086
hsa-miR-125b-5p
SMG5
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.082; TCGA BRCA -0.181; TCGA CESC -0.059; TCGA ESCA -0.135; TCGA HNSC -0.104; TCGA LIHC -0.36; TCGA LUAD -0.119; TCGA LUSC -0.099; TCGA PAAD -0.161; TCGA SARC -0.128; TCGA STAD -0.053; TCGA UCEC -0.12
hsa-miR-125b-5p
SEMA4B
11 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LUSC; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.22; TCGA BRCA -0.116; TCGA COAD -0.126; TCGA HNSC -0.239; TCGA KIRC -0.31; TCGA KIRP -0.13; TCGA LUSC -0.297; TCGA PRAD -0.096; TCGA SARC -0.428; TCGA STAD -0.11; TCGA UCEC -0.091
hsa-miR-125b-5p
ESRRA
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LGG; LUSC; OV; PAAD; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.159; TCGA BRCA -0.152; TCGA CESC -0.121; TCGA COAD -0.108; TCGA ESCA -0.308; TCGA LGG -0.199; TCGA LUSC -0.286; TCGA OV -0.175; TCGA PAAD -0.248; TCGA THCA -0.338; TCGA STAD -0.185; TCGA UCEC -0.16
hsa-miR-125b-5p
TIMM17B
11 cancers: BLCA; BRCA; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC
MirTarget
TCGA BLCA -0.068; TCGA BRCA -0.34; TCGA LGG -0.136; TCGA LIHC -0.198; TCGA LUAD -0.143; TCGA LUSC -0.19; TCGA OV -0.178; TCGA PAAD -0.337; TCGA SARC -0.128; TCGA THCA -0.27; TCGA UCEC -0.1
hsa-miR-125b-5p
SLC26A6
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.089; TCGA BRCA -0.279; TCGA CESC -0.243; TCGA COAD -0.101; TCGA ESCA -0.369; TCGA HNSC -0.222; TCGA KIRP -0.128; TCGA LGG -0.202; TCGA LIHC -0.637; TCGA LUAD -0.128; TCGA LUSC -0.329; TCGA OV -0.232; TCGA PAAD -0.326; TCGA PRAD -0.263; TCGA SARC -0.132; TCGA UCEC -0.24
hsa-miR-125b-5p
B3GNT3
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; STAD; UCEC
MirTarget
TCGA BLCA -0.295; TCGA CESC -0.53; TCGA COAD -0.121; TCGA ESCA -1.091; TCGA HNSC -0.258; TCGA LIHC -0.822; TCGA LUSC -0.368; TCGA OV -0.215; TCGA STAD -0.218; TCGA UCEC -0.492
hsa-miR-125b-5p
VPS4B
9 cancers: BLCA; COAD; HNSC; LGG; LUAD; LUSC; PRAD; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.062; TCGA COAD -0.133; TCGA HNSC -0.066; TCGA LGG -0.063; TCGA LUAD -0.05; TCGA LUSC -0.099; TCGA PRAD -0.085; TCGA THCA -0.065; TCGA STAD -0.158
hsa-miR-125b-5p
DHX33
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.159; TCGA CESC -0.12; TCGA COAD -0.087; TCGA ESCA -0.12; TCGA HNSC -0.118; TCGA LUAD -0.069; TCGA LUSC -0.213; TCGA PRAD -0.276; TCGA THCA -0.267; TCGA STAD -0.138
hsa-miR-125b-5p
NBEAL2
9 cancers: BLCA; BRCA; ESCA; LIHC; LUSC; PRAD; SARC; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.105; TCGA BRCA -0.125; TCGA ESCA -0.289; TCGA LIHC -0.224; TCGA LUSC -0.114; TCGA PRAD -0.241; TCGA SARC -0.152; TCGA STAD -0.225; TCGA UCEC -0.109
hsa-miR-125b-5p
TRAPPC6B
10 cancers: BLCA; COAD; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD
MirTarget; miRNATAP
TCGA BLCA -0.07; TCGA COAD -0.063; TCGA HNSC -0.102; TCGA LGG -0.091; TCGA LUAD -0.093; TCGA LUSC -0.101; TCGA OV -0.06; TCGA PRAD -0.077; TCGA SARC -0.071; TCGA STAD -0.051
hsa-miR-125b-5p
CDC42SE1
13 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PRAD; STAD; UCEC
MirTarget
TCGA BLCA -0.078; TCGA BRCA -0.105; TCGA HNSC -0.077; TCGA KIRC -0.104; TCGA KIRP -0.066; TCGA LGG -0.163; TCGA LIHC -0.157; TCGA LUAD -0.106; TCGA LUSC -0.106; TCGA OV -0.096; TCGA PRAD -0.181; TCGA STAD -0.057; TCGA UCEC -0.102
hsa-miR-125b-5p
SBNO1
9 cancers: BLCA; COAD; ESCA; LUAD; LUSC; PRAD; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.117; TCGA COAD -0.092; TCGA ESCA -0.077; TCGA LUAD -0.14; TCGA LUSC -0.133; TCGA PRAD -0.301; TCGA SARC -0.235; TCGA THCA -0.403; TCGA STAD -0.148
hsa-miR-125b-5p
CASP2
11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUSC; PRAD; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.093; TCGA BRCA -0.084; TCGA COAD -0.078; TCGA KIRC -0.125; TCGA KIRP -0.129; TCGA LGG -0.109; TCGA LIHC -0.257; TCGA LUSC -0.122; TCGA PRAD -0.163; TCGA THCA -0.081; TCGA STAD -0.136
hsa-miR-125b-5p
SLC39A9
12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.091; TCGA BRCA -0.069; TCGA COAD -0.108; TCGA ESCA -0.185; TCGA HNSC -0.104; TCGA LGG -0.131; TCGA LUAD -0.096; TCGA LUSC -0.072; TCGA PAAD -0.087; TCGA PRAD -0.144; TCGA THCA -0.179; TCGA STAD -0.164
hsa-miR-125b-5p
SLC25A15
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.093; TCGA BRCA -0.175; TCGA CESC -0.099; TCGA COAD -0.077; TCGA ESCA -0.308; TCGA HNSC -0.128; TCGA LGG -0.278; TCGA LUAD -0.187; TCGA LUSC -0.256; TCGA OV -0.137; TCGA PRAD -0.266; TCGA THCA -0.821; TCGA STAD -0.187; TCGA UCEC -0.109
hsa-miR-125b-5p
EAF1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.051; TCGA BRCA -0.113; TCGA CESC -0.097; TCGA COAD -0.102; TCGA ESCA -0.236; TCGA HNSC -0.142; TCGA LGG -0.075; TCGA LUAD -0.079; TCGA OV -0.076; TCGA PRAD -0.152; TCGA SARC -0.169; TCGA THCA -0.167; TCGA STAD -0.17; TCGA UCEC -0.077
hsa-miR-125b-5p
PPME1
10 cancers: BLCA; BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC
MirTarget
TCGA BLCA -0.078; TCGA BRCA -0.168; TCGA COAD -0.062; TCGA HNSC -0.116; TCGA KIRC -0.083; TCGA KIRP -0.092; TCGA LIHC -0.137; TCGA LUAD -0.092; TCGA LUSC -0.219; TCGA SARC -0.061
hsa-miR-125b-5p
CPSF6
10 cancers: BLCA; BRCA; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PRAD; STAD
MirTarget; miRNATAP
TCGA BLCA -0.075; TCGA BRCA -0.071; TCGA COAD -0.089; TCGA KIRP -0.058; TCGA LGG -0.065; TCGA LIHC -0.207; TCGA LUAD -0.111; TCGA LUSC -0.142; TCGA PRAD -0.142; TCGA STAD -0.116
hsa-miR-125b-5p
GRSF1
10 cancers: BLCA; BRCA; COAD; ESCA; LUAD; OV; PAAD; PRAD; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.101; TCGA BRCA -0.098; TCGA COAD -0.102; TCGA ESCA -0.102; TCGA LUAD -0.09; TCGA OV -0.081; TCGA PAAD -0.188; TCGA PRAD -0.095; TCGA STAD -0.166; TCGA UCEC -0.054
hsa-miR-125b-5p
TJAP1
9 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; PAAD
MirTarget
TCGA BLCA -0.073; TCGA BRCA -0.071; TCGA ESCA -0.093; TCGA KIRC -0.207; TCGA KIRP -0.07; TCGA LGG -0.074; TCGA LIHC -0.134; TCGA LUSC -0.156; TCGA PAAD -0.142
hsa-miR-125b-5p
MLX
15 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.085; TCGA BRCA -0.064; TCGA CESC -0.052; TCGA COAD -0.122; TCGA ESCA -0.261; TCGA HNSC -0.072; TCGA LGG -0.064; TCGA LUAD -0.1; TCGA LUSC -0.164; TCGA OV -0.165; TCGA PAAD -0.094; TCGA PRAD -0.074; TCGA THCA -0.13; TCGA STAD -0.142; TCGA UCEC -0.085
hsa-miR-125b-5p
RIT1
9 cancers: BLCA; KIRC; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.07; TCGA KIRC -0.299; TCGA LIHC -0.225; TCGA LUAD -0.146; TCGA LUSC -0.344; TCGA OV -0.1; TCGA PRAD -0.102; TCGA SARC -0.11; TCGA UCEC -0.086
hsa-miR-125b-5p
CORO2A
10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; KIRP; LUSC; OV; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.193; TCGA BRCA -0.238; TCGA COAD -0.107; TCGA ESCA -0.336; TCGA KIRC -0.258; TCGA KIRP -0.204; TCGA LUSC -0.267; TCGA OV -0.188; TCGA STAD -0.296; TCGA UCEC -0.197
hsa-miR-125b-5p
MED20
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; THCA; STAD
MirTarget
TCGA BLCA -0.061; TCGA BRCA -0.055; TCGA CESC -0.062; TCGA COAD -0.06; TCGA ESCA -0.179; TCGA HNSC -0.119; TCGA LGG -0.169; TCGA LIHC -0.133; TCGA LUAD -0.094; TCGA LUSC -0.129; TCGA PRAD -0.175; TCGA THCA -0.157; TCGA STAD -0.088
hsa-miR-125b-5p
TMEM161B
11 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; PRAD; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA BLCA -0.162; TCGA BRCA -0.055; TCGA COAD -0.143; TCGA ESCA -0.11; TCGA LGG -0.19; TCGA LUAD -0.064; TCGA LUSC -0.09; TCGA PRAD -0.119; TCGA SARC -0.101; TCGA THCA -0.185; TCGA STAD -0.197
hsa-miR-125b-5p
NDUFA2
9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUSC; OV; PAAD; UCEC
MirTarget
TCGA BLCA -0.086; TCGA BRCA -0.257; TCGA COAD -0.089; TCGA ESCA -0.137; TCGA LGG -0.09; TCGA LUSC -0.114; TCGA OV -0.193; TCGA PAAD -0.271; TCGA UCEC -0.124
hsa-miR-125b-5p
GALNT7
11 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PRAD; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.144; TCGA BRCA -0.248; TCGA COAD -0.144; TCGA ESCA -0.304; TCGA KIRP -0.157; TCGA LIHC -0.172; TCGA LUAD -0.179; TCGA LUSC -0.149; TCGA PRAD -0.148; TCGA STAD -0.253; TCGA UCEC -0.153
hsa-miR-125b-5p
ELOVL6
9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; PRAD; STAD
MirTarget; miRNATAP
TCGA BLCA -0.193; TCGA BRCA -0.128; TCGA COAD -0.204; TCGA ESCA -0.232; TCGA LGG -0.17; TCGA LUAD -0.212; TCGA LUSC -0.174; TCGA PRAD -0.2; TCGA STAD -0.22
hsa-miR-125b-5p
MAP3K10
9 cancers: BLCA; BRCA; CESC; KIRC; KIRP; LUSC; PAAD; SARC; THCA
MirTarget; miRNATAP
TCGA BLCA -0.071; TCGA BRCA -0.28; TCGA CESC -0.081; TCGA KIRC -0.1; TCGA KIRP -0.057; TCGA LUSC -0.198; TCGA PAAD -0.201; TCGA SARC -0.136; TCGA THCA -0.132
hsa-miR-125b-5p
CLN6
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.079; TCGA BRCA -0.223; TCGA CESC -0.081; TCGA COAD -0.137; TCGA ESCA -0.266; TCGA HNSC -0.084; TCGA KIRC -0.092; TCGA LGG -0.129; TCGA LIHC -0.168; TCGA LUAD -0.094; TCGA LUSC -0.146; TCGA OV -0.133; TCGA PAAD -0.162; TCGA SARC -0.101; TCGA STAD -0.162; TCGA UCEC -0.155
hsa-miR-125b-5p
KLC2
12 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUSC; OV; PAAD; SARC; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.093; TCGA BRCA -0.343; TCGA CESC -0.129; TCGA COAD -0.086; TCGA HNSC -0.143; TCGA KIRP -0.073; TCGA LIHC -0.279; TCGA LUSC -0.276; TCGA OV -0.066; TCGA PAAD -0.135; TCGA SARC -0.164; TCGA UCEC -0.064
hsa-miR-125b-5p
HAPLN1
13 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; OV; PAAD; STAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.693; TCGA BRCA -0.529; TCGA CESC -0.389; TCGA COAD -0.284; TCGA HNSC -0.429; TCGA KIRC -1.012; TCGA KIRP -0.397; TCGA LGG -0.858; TCGA LIHC -0.368; TCGA OV -0.346; TCGA PAAD -0.734; TCGA STAD -0.638; TCGA UCEC -0.199
hsa-miR-125b-5p
CYB561
10 cancers: BLCA; BRCA; ESCA; KIRP; LIHC; LUAD; PAAD; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.092; TCGA BRCA -0.295; TCGA ESCA -0.242; TCGA KIRP -0.058; TCGA LIHC -0.258; TCGA LUAD -0.093; TCGA PAAD -0.323; TCGA THCA -0.252; TCGA STAD -0.181; TCGA UCEC -0.086
hsa-miR-125b-5p
DDX11
9 cancers: BLCA; BRCA; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; STAD
mirMAP
TCGA BLCA -0.117; TCGA BRCA -0.215; TCGA KIRC -0.261; TCGA LGG -0.271; TCGA LIHC -0.408; TCGA LUAD -0.122; TCGA LUSC -0.316; TCGA PAAD -0.28; TCGA STAD -0.185
hsa-miR-125b-5p
WBSCR22
10 cancers: BLCA; BRCA; ESCA; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC
mirMAP
TCGA BLCA -0.059; TCGA BRCA -0.214; TCGA ESCA -0.139; TCGA LGG -0.081; TCGA LIHC -0.1; TCGA LUSC -0.192; TCGA OV -0.073; TCGA PAAD -0.307; TCGA STAD -0.094; TCGA UCEC -0.089
hsa-miR-125b-5p
MARK2
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PRAD; STAD
mirMAP; miRNATAP
TCGA BLCA -0.09; TCGA BRCA -0.132; TCGA CESC -0.051; TCGA COAD -0.078; TCGA ESCA -0.148; TCGA HNSC -0.073; TCGA LIHC -0.105; TCGA LUSC -0.105; TCGA PRAD -0.076; TCGA STAD -0.103
hsa-miR-125b-5p
ATXN7L3
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; STAD
mirMAP
TCGA BLCA -0.115; TCGA BRCA -0.125; TCGA ESCA -0.081; TCGA HNSC -0.101; TCGA KIRP -0.056; TCGA LIHC -0.161; TCGA LUAD -0.079; TCGA LUSC -0.134; TCGA PRAD -0.055; TCGA STAD -0.068
hsa-miR-125b-5p
DNAJC5
9 cancers: BLCA; BRCA; HNSC; LIHC; OV; PAAD; PRAD; THCA; STAD
mirMAP
TCGA BLCA -0.066; TCGA BRCA -0.138; TCGA HNSC -0.096; TCGA LIHC -0.229; TCGA OV -0.074; TCGA PAAD -0.197; TCGA PRAD -0.089; TCGA THCA -0.077; TCGA STAD -0.066
hsa-miR-125b-5p
MOGS
14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; STAD; UCEC
mirMAP
TCGA BLCA -0.066; TCGA BRCA -0.217; TCGA CESC -0.128; TCGA ESCA -0.137; TCGA HNSC -0.101; TCGA KIRC -0.181; TCGA KIRP -0.128; TCGA LGG -0.121; TCGA LIHC -0.089; TCGA LUSC -0.22; TCGA PAAD -0.278; TCGA PRAD -0.133; TCGA STAD -0.094; TCGA UCEC -0.091
hsa-miR-125b-5p
PIGZ
11 cancers: BLCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; SARC; THCA; UCEC
mirMAP
TCGA BLCA -0.215; TCGA KIRC -0.237; TCGA KIRP -0.156; TCGA LGG -0.175; TCGA LIHC -0.319; TCGA LUSC -0.355; TCGA OV -0.279; TCGA PAAD -0.211; TCGA SARC -0.15; TCGA THCA -0.323; TCGA UCEC -0.23
hsa-miR-125b-5p
SLC25A35
10 cancers: BLCA; BRCA; ESCA; LGG; LIHC; LUAD; OV; PAAD; SARC; THCA
mirMAP
TCGA BLCA -0.087; TCGA BRCA -0.209; TCGA ESCA -0.112; TCGA LGG -0.1; TCGA LIHC -0.206; TCGA LUAD -0.135; TCGA OV -0.156; TCGA PAAD -0.141; TCGA SARC -0.096; TCGA THCA -0.144
hsa-miR-125b-5p
XRCC3
15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.124; TCGA BRCA -0.226; TCGA CESC -0.084; TCGA COAD -0.187; TCGA HNSC -0.178; TCGA KIRC -0.239; TCGA KIRP -0.102; TCGA LGG -0.17; TCGA LIHC -0.375; TCGA LUSC -0.33; TCGA OV -0.083; TCGA PAAD -0.391; TCGA SARC -0.146; TCGA STAD -0.114; TCGA UCEC -0.092
hsa-miR-125b-5p
TOMM40
12 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; STAD; UCEC
mirMAP
TCGA BLCA -0.077; TCGA BRCA -0.289; TCGA CESC -0.107; TCGA COAD -0.124; TCGA ESCA -0.231; TCGA HNSC -0.144; TCGA LIHC -0.289; TCGA LUSC -0.286; TCGA OV -0.112; TCGA PAAD -0.278; TCGA STAD -0.196; TCGA UCEC -0.123
hsa-miR-125b-5p
ANKRD52
9 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; THCA
mirMAP
TCGA BLCA -0.079; TCGA BRCA -0.08; TCGA CESC -0.067; TCGA COAD -0.053; TCGA ESCA -0.109; TCGA LIHC -0.387; TCGA LUAD -0.07; TCGA LUSC -0.11; TCGA THCA -0.121
hsa-miR-125b-5p
ZBTB7B
11 cancers: BLCA; BRCA; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.188; TCGA BRCA -0.217; TCGA COAD -0.086; TCGA ESCA -0.151; TCGA HNSC -0.079; TCGA KIRC -0.12; TCGA LUAD -0.094; TCGA LUSC -0.17; TCGA SARC -0.27; TCGA STAD -0.119; TCGA UCEC -0.118
hsa-miR-125b-5p
NACC1
10 cancers: BLCA; BRCA; CESC; COAD; HNSC; LIHC; LUSC; PAAD; STAD; UCEC
mirMAP
TCGA BLCA -0.112; TCGA BRCA -0.336; TCGA CESC -0.112; TCGA COAD -0.091; TCGA HNSC -0.155; TCGA LIHC -0.138; TCGA LUSC -0.224; TCGA PAAD -0.171; TCGA STAD -0.07; TCGA UCEC -0.065
hsa-miR-125b-5p
LRRC14
10 cancers: BLCA; BRCA; COAD; LGG; LIHC; LUSC; OV; PAAD; SARC; STAD
mirMAP
TCGA BLCA -0.104; TCGA BRCA -0.211; TCGA COAD -0.08; TCGA LGG -0.131; TCGA LIHC -0.304; TCGA LUSC -0.126; TCGA OV -0.107; TCGA PAAD -0.279; TCGA SARC -0.1; TCGA STAD -0.071
hsa-miR-125b-5p
SLC25A10
11 cancers: BLCA; BRCA; COAD; ESCA; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC
mirMAP
TCGA BLCA -0.19; TCGA BRCA -0.322; TCGA COAD -0.177; TCGA ESCA -0.339; TCGA LUAD -0.155; TCGA LUSC -0.334; TCGA OV -0.146; TCGA PAAD -0.459; TCGA THCA -0.081; TCGA STAD -0.18; TCGA UCEC -0.154
hsa-miR-125b-5p
TMEM184B
9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; PAAD; UCEC
mirMAP
TCGA BLCA -0.059; TCGA BRCA -0.11; TCGA CESC -0.059; TCGA HNSC -0.124; TCGA KIRC -0.104; TCGA LGG -0.061; TCGA LIHC -0.199; TCGA PAAD -0.113; TCGA UCEC -0.082
hsa-miR-125b-5p
PFDN6
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
mirMAP
TCGA BLCA -0.084; TCGA BRCA -0.315; TCGA CESC -0.168; TCGA COAD -0.072; TCGA ESCA -0.171; TCGA HNSC -0.111; TCGA LIHC -0.192; TCGA LUAD -0.125; TCGA LUSC -0.25; TCGA OV -0.109; TCGA PAAD -0.268; TCGA STAD -0.14; TCGA UCEC -0.16
hsa-miR-125b-5p
DDR1
12 cancers: BLCA; BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD
mirMAP
TCGA BLCA -0.196; TCGA BRCA -0.248; TCGA COAD -0.071; TCGA HNSC -0.077; TCGA KIRP -0.116; TCGA LGG -0.145; TCGA LIHC -0.491; TCGA LUSC -0.145; TCGA PAAD -0.178; TCGA PRAD -0.165; TCGA SARC -0.152; TCGA STAD -0.174
hsa-miR-125b-5p
NECAB3
12 cancers: BLCA; BRCA; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.061; TCGA BRCA -0.455; TCGA ESCA -0.104; TCGA LGG -0.142; TCGA LIHC -0.235; TCGA LUAD -0.135; TCGA LUSC -0.17; TCGA PAAD -0.433; TCGA SARC -0.152; TCGA THCA -0.223; TCGA STAD -0.104; TCGA UCEC -0.099
hsa-miR-125b-5p
ZFP62
11 cancers: BLCA; BRCA; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.211; TCGA BRCA -0.093; TCGA KIRP -0.071; TCGA LGG -0.11; TCGA LIHC -0.2; TCGA LUAD -0.075; TCGA PAAD -0.106; TCGA PRAD -0.136; TCGA SARC -0.104; TCGA THCA -0.086; TCGA STAD -0.125
hsa-miR-125b-5p
KIAA1841
9 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; STAD
miRNATAP
TCGA BLCA -0.053; TCGA BRCA -0.155; TCGA KIRC -0.198; TCGA KIRP -0.215; TCGA LIHC -0.437; TCGA LUAD -0.171; TCGA LUSC -0.234; TCGA OV -0.101; TCGA STAD -0.133
hsa-miR-125b-5p
YOD1
10 cancers: BLCA; CESC; COAD; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; STAD
miRNATAP
TCGA BLCA -0.157; TCGA CESC -0.083; TCGA COAD -0.117; TCGA HNSC -0.15; TCGA LIHC -0.076; TCGA LUAD -0.174; TCGA LUSC -0.179; TCGA PRAD -0.183; TCGA SARC -0.065; TCGA STAD -0.281
hsa-miR-125b-5p
KIAA1522
10 cancers: BLCA; BRCA; COAD; ESCA; LIHC; LUSC; PRAD; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.235; TCGA BRCA -0.204; TCGA COAD -0.093; TCGA ESCA -0.147; TCGA LIHC -0.442; TCGA LUSC -0.119; TCGA PRAD -0.089; TCGA SARC -0.376; TCGA STAD -0.219; TCGA UCEC -0.077
hsa-miR-125b-5p
ITCH
10 cancers: BLCA; CESC; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.08; TCGA CESC -0.052; TCGA HNSC -0.083; TCGA LUAD -0.08; TCGA LUSC -0.074; TCGA PRAD -0.132; TCGA SARC -0.085; TCGA THCA -0.129; TCGA STAD -0.097; TCGA UCEC -0.073
hsa-miR-125b-5p
AIFM1
13 cancers: BLCA; BRCA; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.087; TCGA BRCA -0.203; TCGA COAD -0.065; TCGA ESCA -0.223; TCGA LGG -0.059; TCGA LUAD -0.094; TCGA LUSC -0.224; TCGA OV -0.109; TCGA PAAD -0.153; TCGA PRAD -0.106; TCGA THCA -0.274; TCGA STAD -0.213; TCGA UCEC -0.123
hsa-miR-125b-5p
HNRNPA2B1
10 cancers: BLCA; BRCA; COAD; ESCA; KIRP; LIHC; LUAD; LUSC; PRAD; STAD
miRNATAP
TCGA BLCA -0.057; TCGA BRCA -0.167; TCGA COAD -0.065; TCGA ESCA -0.106; TCGA KIRP -0.05; TCGA LIHC -0.101; TCGA LUAD -0.057; TCGA LUSC -0.158; TCGA PRAD -0.091; TCGA STAD -0.181
hsa-miR-125b-5p
FBXL19
9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LIHC; LUSC; PAAD
miRNATAP
TCGA BLCA -0.111; TCGA BRCA -0.294; TCGA CESC -0.055; TCGA HNSC -0.107; TCGA KIRC -0.099; TCGA LGG -0.174; TCGA LIHC -0.274; TCGA LUSC -0.249; TCGA PAAD -0.129
hsa-miR-125b-5p
ZDHHC9
14 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; OV; PRAD; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.094; TCGA BRCA -0.124; TCGA CESC -0.121; TCGA ESCA -0.301; TCGA HNSC -0.193; TCGA KIRC -0.095; TCGA LGG -0.086; TCGA LIHC -0.134; TCGA LUSC -0.186; TCGA OV -0.073; TCGA PRAD -0.192; TCGA THCA -0.079; TCGA STAD -0.208; TCGA UCEC -0.053
hsa-miR-125b-5p
AKAP1
10 cancers: BLCA; CESC; ESCA; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.134; TCGA CESC -0.063; TCGA ESCA -0.357; TCGA LUAD -0.108; TCGA LUSC -0.204; TCGA OV -0.066; TCGA PAAD -0.154; TCGA SARC -0.542; TCGA THCA -0.068; TCGA STAD -0.154
hsa-miR-125b-5p
PTPN18
10 cancers: BLCA; BRCA; ESCA; KIRC; KIRP; OV; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.077; TCGA BRCA -0.079; TCGA ESCA -0.253; TCGA KIRC -0.164; TCGA KIRP -0.067; TCGA OV -0.077; TCGA SARC -0.13; TCGA THCA -0.152; TCGA STAD -0.062; TCGA UCEC -0.113
hsa-miR-125b-5p
JUP
9 cancers: BLCA; BRCA; ESCA; HNSC; KIRP; LUSC; PAAD; STAD; UCEC
miRNATAP
TCGA BLCA -0.178; TCGA BRCA -0.189; TCGA ESCA -0.231; TCGA HNSC -0.394; TCGA KIRP -0.077; TCGA LUSC -0.377; TCGA PAAD -0.208; TCGA STAD -0.288; TCGA UCEC -0.088
hsa-miR-125b-5p
FAM126B
9 cancers: BLCA; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.097; TCGA ESCA -0.126; TCGA HNSC -0.117; TCGA LUAD -0.178; TCGA LUSC -0.091; TCGA PRAD -0.201; TCGA THCA -0.118; TCGA STAD -0.113; TCGA UCEC -0.071
hsa-miR-125b-5p
SOCS4
10 cancers: BLCA; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.102; TCGA COAD -0.098; TCGA ESCA -0.082; TCGA HNSC -0.115; TCGA LUAD -0.113; TCGA LUSC -0.093; TCGA PRAD -0.133; TCGA SARC -0.147; TCGA THCA -0.134; TCGA STAD -0.15
hsa-miR-125b-5p
GTPBP2
16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; PAAD; PRAD; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.12; TCGA BRCA -0.132; TCGA CESC -0.061; TCGA COAD -0.071; TCGA ESCA -0.191; TCGA HNSC -0.068; TCGA KIRC -0.29; TCGA KIRP -0.173; TCGA LGG -0.063; TCGA LIHC -0.24; TCGA LUSC -0.161; TCGA PAAD -0.091; TCGA PRAD -0.143; TCGA SARC -0.062; TCGA STAD -0.084; TCGA UCEC -0.059
hsa-miR-125b-5p
ATP13A3
12 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.108; TCGA BRCA -0.05; TCGA CESC -0.139; TCGA ESCA -0.152; TCGA HNSC -0.225; TCGA KIRC -0.17; TCGA LUAD -0.159; TCGA LUSC -0.314; TCGA PRAD -0.142; TCGA SARC -0.188; TCGA STAD -0.202; TCGA UCEC -0.114
hsa-miR-125b-5p
PI4K2B
11 cancers: BLCA; COAD; ESCA; HNSC; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BLCA -0.072; TCGA COAD -0.108; TCGA ESCA -0.126; TCGA HNSC -0.058; TCGA LUAD -0.13; TCGA OV -0.173; TCGA PRAD -0.205; TCGA SARC -0.175; TCGA THCA -0.172; TCGA STAD -0.291; TCGA UCEC -0.095
hsa-miR-125b-5p
PIK3C2B
9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LGG; PRAD; THCA; STAD
miRNATAP
TCGA BLCA -0.221; TCGA COAD -0.064; TCGA ESCA -0.219; TCGA KIRC -0.164; TCGA KIRP -0.142; TCGA LGG -0.15; TCGA PRAD -0.14; TCGA THCA -0.354; TCGA STAD -0.101
hsa-miR-125b-5p
FMR1
9 cancers: BLCA; BRCA; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD
miRNATAP
TCGA BLCA -0.102; TCGA BRCA -0.055; TCGA LGG -0.089; TCGA LUAD -0.11; TCGA LUSC -0.11; TCGA OV -0.074; TCGA PRAD -0.085; TCGA SARC -0.096; TCGA STAD -0.116
hsa-miR-125b-5p
TUBG1
14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD; UCEC
miRNATAP
TCGA BLCA -0.121; TCGA BRCA -0.288; TCGA CESC -0.054; TCGA COAD -0.128; TCGA ESCA -0.154; TCGA HNSC -0.168; TCGA LIHC -0.289; TCGA LUAD -0.142; TCGA LUSC -0.329; TCGA OV -0.156; TCGA PAAD -0.283; TCGA SARC -0.233; TCGA STAD -0.117; TCGA UCEC -0.089
hsa-miR-125b-5p
BAZ2A
10 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PRAD; STAD
miRNATAP
TCGA BLCA -0.096; TCGA CESC -0.122; TCGA HNSC -0.139; TCGA KIRC -0.157; TCGA KIRP -0.108; TCGA LIHC -0.213; TCGA LUAD -0.115; TCGA LUSC -0.081; TCGA PRAD -0.236; TCGA STAD -0.062
hsa-miR-125b-5p
HMGB3
13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRNATAP
TCGA BLCA -0.143; TCGA BRCA -0.462; TCGA CESC -0.138; TCGA COAD -0.088; TCGA HNSC -0.203; TCGA LGG -0.293; TCGA LIHC -0.137; TCGA LUAD -0.341; TCGA LUSC -0.565; TCGA OV -0.1; TCGA PAAD -0.3; TCGA STAD -0.297; TCGA UCEC -0.118
hsa-miR-125b-5p
AURKB
16 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.695; TCGA CESC -0.112; TCGA COAD -0.165; TCGA ESCA -0.209; TCGA HNSC -0.217; TCGA KIRC -0.684; TCGA KIRP -0.46; TCGA LGG -0.492; TCGA LIHC -1.08; TCGA LUAD -0.353; TCGA LUSC -0.63; TCGA OV -0.263; TCGA PAAD -0.449; TCGA PRAD -0.194; TCGA STAD -0.351; TCGA UCEC -0.33
hsa-miR-125b-5p
B4GALT3
12 cancers: BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.234; TCGA CESC -0.055; TCGA ESCA -0.136; TCGA HNSC -0.08; TCGA LGG -0.155; TCGA LIHC -0.227; TCGA LUAD -0.119; TCGA LUSC -0.144; TCGA OV -0.065; TCGA PAAD -0.19; TCGA STAD -0.104; TCGA UCEC -0.088
hsa-miR-125b-5p
BBC3
9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; PAAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BRCA -0.362; TCGA ESCA -0.133; TCGA KIRC -0.347; TCGA KIRP -0.161; TCGA LGG -0.104; TCGA LIHC -0.252; TCGA PAAD -0.399; TCGA STAD -0.115; TCGA UCEC -0.086
hsa-miR-125b-5p
CCNE1
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.382; TCGA CESC -0.128; TCGA COAD -0.153; TCGA ESCA -0.262; TCGA HNSC -0.277; TCGA KIRP -0.236; TCGA LIHC -0.798; TCGA LUAD -0.213; TCGA LUSC -0.583; TCGA OV -0.273; TCGA SARC -0.31; TCGA STAD -0.329; TCGA UCEC -0.255
hsa-miR-125b-5p
CHPF2
9 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; PAAD; PRAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.136; TCGA CESC -0.101; TCGA HNSC -0.144; TCGA KIRC -0.114; TCGA KIRP -0.108; TCGA LIHC -0.13; TCGA PAAD -0.214; TCGA PRAD -0.111; TCGA UCEC -0.083
hsa-miR-125b-5p
E2F2
13 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BRCA -0.494; TCGA COAD -0.236; TCGA ESCA -0.216; TCGA KIRC -0.625; TCGA KIRP -0.359; TCGA LIHC -0.8; TCGA LUAD -0.257; TCGA LUSC -0.333; TCGA OV -0.141; TCGA PRAD -0.292; TCGA SARC -0.194; TCGA STAD -0.435; TCGA UCEC -0.307
hsa-miR-125b-5p
EDEM1
10 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BRCA -0.053; TCGA CESC -0.072; TCGA COAD -0.057; TCGA ESCA -0.103; TCGA KIRC -0.119; TCGA KIRP -0.065; TCGA PRAD -0.12; TCGA SARC -0.097; TCGA STAD -0.125; TCGA UCEC -0.083
hsa-miR-125b-5p
EIF4EBP1
13 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; STAD; UCEC
miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP
TCGA BRCA -0.288; TCGA COAD -0.14; TCGA HNSC -0.246; TCGA KIRC -0.329; TCGA KIRP -0.129; TCGA LGG -0.308; TCGA LIHC -0.117; TCGA LUAD -0.144; TCGA LUSC -0.502; TCGA PAAD -0.427; TCGA THCA -0.168; TCGA STAD -0.107; TCGA UCEC -0.145
hsa-miR-125b-5p
GPRIN1
10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.535; TCGA COAD -0.131; TCGA HNSC -0.487; TCGA KIRC -0.47; TCGA KIRP -0.433; TCGA LGG -0.466; TCGA LIHC -0.766; TCGA LUSC -0.373; TCGA STAD -0.163; TCGA UCEC -0.209
hsa-miR-125b-5p
HDGF
13 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.256; TCGA CESC -0.098; TCGA ESCA -0.181; TCGA HNSC -0.113; TCGA KIRP -0.105; TCGA LIHC -0.083; TCGA LUAD -0.174; TCGA LUSC -0.209; TCGA OV -0.066; TCGA PAAD -0.128; TCGA PRAD -0.077; TCGA STAD -0.163; TCGA UCEC -0.128
hsa-miR-125b-5p
HMGA1
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BRCA -0.339; TCGA CESC -0.175; TCGA COAD -0.182; TCGA ESCA -0.277; TCGA HNSC -0.205; TCGA KIRP -0.185; TCGA LIHC -0.65; TCGA LUSC -0.368; TCGA PAAD -0.316; TCGA STAD -0.216; TCGA UCEC -0.218
hsa-miR-125b-5p
HSPBP1
10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.268; TCGA CESC -0.095; TCGA COAD -0.077; TCGA ESCA -0.123; TCGA HNSC -0.067; TCGA LIHC -0.12; TCGA LUSC -0.097; TCGA PAAD -0.43; TCGA STAD -0.078; TCGA UCEC -0.057
hsa-miR-125b-5p
KPNB1
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.098; TCGA CESC -0.07; TCGA COAD -0.113; TCGA ESCA -0.074; TCGA HNSC -0.096; TCGA LIHC -0.175; TCGA LUAD -0.145; TCGA LUSC -0.163; TCGA PRAD -0.141; TCGA SARC -0.086; TCGA THCA -0.13; TCGA STAD -0.12; TCGA UCEC -0.055
hsa-miR-125b-5p
LACTB
12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC
miRNAWalker2 validate; MirTarget
TCGA BRCA -0.078; TCGA CESC -0.156; TCGA COAD -0.054; TCGA ESCA -0.187; TCGA HNSC -0.177; TCGA LUSC -0.097; TCGA OV -0.17; TCGA PRAD -0.236; TCGA SARC -0.163; TCGA THCA -0.195; TCGA STAD -0.099; TCGA UCEC -0.186
hsa-miR-125b-5p
MRTO4
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.106; TCGA CESC -0.082; TCGA COAD -0.104; TCGA ESCA -0.115; TCGA HNSC -0.173; TCGA KIRC -0.073; TCGA LIHC -0.202; TCGA LUAD -0.077; TCGA LUSC -0.116; TCGA OV -0.074; TCGA PAAD -0.161; TCGA STAD -0.14; TCGA UCEC -0.081
hsa-miR-125b-5p
MUC1
10 cancers: BRCA; CESC; COAD; ESCA; LIHC; OV; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.231; TCGA CESC -0.2; TCGA COAD -0.247; TCGA ESCA -0.768; TCGA LIHC -0.423; TCGA OV -0.162; TCGA PRAD -0.244; TCGA SARC -0.656; TCGA STAD -0.386; TCGA UCEC -0.39
hsa-miR-125b-5p
NRARP
9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BRCA -0.17; TCGA COAD -0.215; TCGA ESCA -0.335; TCGA HNSC -0.197; TCGA KIRC -0.405; TCGA LIHC -0.136; TCGA LUSC -0.422; TCGA PRAD -0.141; TCGA STAD -0.206
hsa-miR-125b-5p
PLEKHA8
10 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.113; TCGA CESC -0.153; TCGA ESCA -0.109; TCGA HNSC -0.167; TCGA LIHC -0.138; TCGA LUAD -0.103; TCGA LUSC -0.28; TCGA THCA -0.192; TCGA STAD -0.126; TCGA UCEC -0.097
hsa-miR-125b-5p
PSMB1
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; PRAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.094; TCGA CESC -0.074; TCGA COAD -0.101; TCGA ESCA -0.084; TCGA HNSC -0.099; TCGA LGG -0.13; TCGA LIHC -0.069; TCGA LUSC -0.119; TCGA OV -0.126; TCGA PAAD -0.143; TCGA PRAD -0.126; TCGA STAD -0.086; TCGA UCEC -0.102
hsa-miR-125b-5p
QSOX2
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; STAD
miRNAWalker2 validate; miRNATAP
TCGA BRCA -0.1; TCGA CESC -0.106; TCGA COAD -0.061; TCGA ESCA -0.193; TCGA HNSC -0.136; TCGA KIRC -0.167; TCGA LGG -0.098; TCGA LIHC -0.112; TCGA LUAD -0.063; TCGA LUSC -0.188; TCGA PAAD -0.143; TCGA PRAD -0.163; TCGA STAD -0.181
hsa-miR-125b-5p
RFWD3
9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNAWalker2 validate
TCGA BRCA -0.086; TCGA COAD -0.093; TCGA HNSC -0.146; TCGA LGG -0.084; TCGA LIHC -0.166; TCGA LUAD -0.116; TCGA LUSC -0.21; TCGA PRAD -0.149; TCGA STAD -0.174
hsa-miR-125b-5p
RNASEH2A
13 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.414; TCGA COAD -0.13; TCGA HNSC -0.093; TCGA KIRC -0.109; TCGA KIRP -0.117; TCGA LGG -0.217; TCGA LIHC -0.415; TCGA LUAD -0.104; TCGA LUSC -0.304; TCGA PAAD -0.386; TCGA SARC -0.141; TCGA STAD -0.171; TCGA UCEC -0.092
hsa-miR-125b-5p
RRP7A
10 cancers: BRCA; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate; mirMAP
TCGA BRCA -0.119; TCGA COAD -0.084; TCGA ESCA -0.103; TCGA HNSC -0.163; TCGA LIHC -0.137; TCGA LUSC -0.13; TCGA OV -0.099; TCGA PAAD -0.284; TCGA STAD -0.062; TCGA UCEC -0.13
hsa-miR-125b-5p
SLC35A4
10 cancers: BRCA; COAD; ESCA; LGG; LIHC; OV; PAAD; SARC; THCA; STAD
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA BRCA -0.061; TCGA COAD -0.078; TCGA ESCA -0.081; TCGA LGG -0.132; TCGA LIHC -0.062; TCGA OV -0.066; TCGA PAAD -0.085; TCGA SARC -0.075; TCGA THCA -0.171; TCGA STAD -0.055
hsa-miR-125b-5p
SMC2
12 cancers: BRCA; COAD; ESCA; LGG; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD
miRNAWalker2 validate
TCGA BRCA -0.088; TCGA COAD -0.157; TCGA ESCA -0.146; TCGA LGG -0.107; TCGA LIHC -0.203; TCGA LUAD -0.114; TCGA LUSC -0.223; TCGA OV -0.098; TCGA PRAD -0.254; TCGA SARC -0.131; TCGA THCA -0.11; TCGA STAD -0.315
hsa-miR-125b-5p
TIMM10
10 cancers: BRCA; COAD; ESCA; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC
miRNAWalker2 validate
TCGA BRCA -0.198; TCGA COAD -0.076; TCGA ESCA -0.156; TCGA LGG -0.142; TCGA LUAD -0.107; TCGA LUSC -0.183; TCGA OV -0.169; TCGA PAAD -0.148; TCGA STAD -0.072; TCGA UCEC -0.091
hsa-miR-125b-5p
EIF1AD
12 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.092; TCGA CESC -0.07; TCGA COAD -0.059; TCGA HNSC -0.147; TCGA KIRC -0.054; TCGA KIRP -0.053; TCGA LGG -0.077; TCGA LIHC -0.108; TCGA LUAD -0.051; TCGA LUSC -0.143; TCGA OV -0.065; TCGA UCEC -0.054
hsa-miR-125b-5p
PSMB8
11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; OV; SARC; STAD; UCEC
MirTarget
TCGA BRCA -0.17; TCGA COAD -0.109; TCGA ESCA -0.173; TCGA HNSC -0.151; TCGA KIRC -0.34; TCGA KIRP -0.125; TCGA LGG -0.145; TCGA OV -0.231; TCGA SARC -0.166; TCGA STAD -0.122; TCGA UCEC -0.159
hsa-miR-125b-5p
CDR2L
9 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LUSC; OV; PRAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.145; TCGA CESC -0.193; TCGA ESCA -0.434; TCGA HNSC -0.147; TCGA KIRP -0.136; TCGA LUSC -0.287; TCGA OV -0.287; TCGA PRAD -0.345; TCGA UCEC -0.169
hsa-miR-125b-5p
PMM2
15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.193; TCGA CESC -0.169; TCGA COAD -0.091; TCGA ESCA -0.237; TCGA HNSC -0.131; TCGA KIRC -0.196; TCGA LGG -0.121; TCGA LIHC -0.126; TCGA LUSC -0.126; TCGA OV -0.082; TCGA PAAD -0.242; TCGA PRAD -0.107; TCGA THCA -0.077; TCGA STAD -0.188; TCGA UCEC -0.184
hsa-miR-125b-5p
DPH2
16 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.153; TCGA CESC -0.15; TCGA COAD -0.069; TCGA ESCA -0.21; TCGA HNSC -0.092; TCGA KIRP -0.067; TCGA LIHC -0.259; TCGA LUAD -0.076; TCGA LUSC -0.186; TCGA OV -0.123; TCGA PAAD -0.116; TCGA PRAD -0.271; TCGA SARC -0.113; TCGA THCA -0.106; TCGA STAD -0.193; TCGA UCEC -0.091
hsa-miR-125b-5p
BRMS1
11 cancers: BRCA; CESC; ESCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC
MirTarget
TCGA BRCA -0.252; TCGA CESC -0.11; TCGA ESCA -0.135; TCGA HNSC -0.267; TCGA LGG -0.138; TCGA LIHC -0.203; TCGA LUSC -0.168; TCGA OV -0.113; TCGA PAAD -0.216; TCGA STAD -0.084; TCGA UCEC -0.115
hsa-miR-125b-5p
TOR2A
15 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.312; TCGA CESC -0.066; TCGA COAD -0.114; TCGA ESCA -0.293; TCGA HNSC -0.154; TCGA KIRC -0.085; TCGA LGG -0.199; TCGA LIHC -0.117; TCGA LUSC -0.178; TCGA OV -0.219; TCGA PAAD -0.299; TCGA PRAD -0.107; TCGA THCA -0.115; TCGA STAD -0.126; TCGA UCEC -0.128
hsa-miR-125b-5p
TRIM14
10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; OV; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BRCA -0.114; TCGA COAD -0.094; TCGA ESCA -0.133; TCGA HNSC -0.111; TCGA KIRC -0.384; TCGA OV -0.145; TCGA PRAD -0.23; TCGA SARC -0.284; TCGA STAD -0.133; TCGA UCEC -0.117
hsa-miR-125b-5p
B3GALNT2
10 cancers: BRCA; COAD; HNSC; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD
MirTarget
TCGA BRCA -0.099; TCGA COAD -0.072; TCGA HNSC -0.062; TCGA LIHC -0.194; TCGA LUAD -0.144; TCGA LUSC -0.108; TCGA PAAD -0.106; TCGA SARC -0.179; TCGA THCA -0.222; TCGA STAD -0.073
hsa-miR-125b-5p
DCAF10
9 cancers: BRCA; CESC; HNSC; LUAD; LUSC; PRAD; SARC; THCA; STAD
MirTarget
TCGA BRCA -0.117; TCGA CESC -0.061; TCGA HNSC -0.105; TCGA LUAD -0.114; TCGA LUSC -0.125; TCGA PRAD -0.121; TCGA SARC -0.072; TCGA THCA -0.092; TCGA STAD -0.064
hsa-miR-125b-5p
CDK16
10 cancers: BRCA; COAD; LIHC; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.163; TCGA COAD -0.083; TCGA LIHC -0.28; TCGA LUAD -0.1; TCGA LUSC -0.117; TCGA OV -0.11; TCGA PAAD -0.164; TCGA PRAD -0.065; TCGA STAD -0.118; TCGA UCEC -0.086
hsa-miR-125b-5p
CIAPIN1
13 cancers: BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.086; TCGA CESC -0.056; TCGA COAD -0.078; TCGA HNSC -0.179; TCGA LGG -0.165; TCGA LIHC -0.088; TCGA LUAD -0.061; TCGA LUSC -0.079; TCGA OV -0.09; TCGA PRAD -0.115; TCGA THCA -0.183; TCGA STAD -0.078; TCGA UCEC -0.058
hsa-miR-125b-5p
SCLY
9 cancers: BRCA; COAD; ESCA; KIRP; LGG; LUAD; SARC; STAD; UCEC
MirTarget
TCGA BRCA -0.187; TCGA COAD -0.118; TCGA ESCA -0.172; TCGA KIRP -0.077; TCGA LGG -0.212; TCGA LUAD -0.1; TCGA SARC -0.099; TCGA STAD -0.083; TCGA UCEC -0.06
hsa-miR-125b-5p
SYVN1
9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; PAAD; PRAD; THCA; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.125; TCGA CESC -0.095; TCGA ESCA -0.068; TCGA HNSC -0.06; TCGA KIRC -0.113; TCGA PAAD -0.177; TCGA PRAD -0.063; TCGA THCA -0.112; TCGA UCEC -0.073
hsa-miR-125b-5p
COPS7B
9 cancers: BRCA; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; STAD
MirTarget; miRNATAP
TCGA BRCA -0.077; TCGA ESCA -0.064; TCGA KIRP -0.097; TCGA LGG -0.127; TCGA LIHC -0.194; TCGA LUAD -0.072; TCGA LUSC -0.081; TCGA PAAD -0.166; TCGA STAD -0.065
hsa-miR-125b-5p
PSMG3
12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; STAD; UCEC
MirTarget
TCGA BRCA -0.251; TCGA CESC -0.086; TCGA COAD -0.091; TCGA ESCA -0.124; TCGA HNSC -0.099; TCGA LGG -0.151; TCGA LIHC -0.287; TCGA LUAD -0.081; TCGA LUSC -0.225; TCGA PAAD -0.454; TCGA STAD -0.146; TCGA UCEC -0.114
hsa-miR-125b-5p
USP37
9 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD
MirTarget; miRNATAP
TCGA BRCA -0.065; TCGA ESCA -0.124; TCGA KIRC -0.103; TCGA KIRP -0.073; TCGA LIHC -0.158; TCGA LUAD -0.232; TCGA PRAD -0.12; TCGA SARC -0.147; TCGA STAD -0.189
hsa-miR-125b-5p
TRIAP1
13 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.072; TCGA COAD -0.092; TCGA ESCA -0.117; TCGA KIRC -0.057; TCGA KIRP -0.064; TCGA LGG -0.193; TCGA LUAD -0.107; TCGA LUSC -0.071; TCGA PAAD -0.183; TCGA PRAD -0.055; TCGA THCA -0.053; TCGA STAD -0.139; TCGA UCEC -0.061
hsa-miR-125b-5p
TXNRD1
11 cancers: BRCA; CESC; COAD; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.056; TCGA CESC -0.12; TCGA COAD -0.108; TCGA LIHC -0.233; TCGA LUAD -0.195; TCGA LUSC -0.508; TCGA PRAD -0.178; TCGA SARC -0.227; TCGA THCA -0.362; TCGA STAD -0.139; TCGA UCEC -0.135
hsa-miR-125b-5p
PDIA3
12 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; PAAD; PRAD; STAD; UCEC
MirTarget
TCGA BRCA -0.173; TCGA CESC -0.066; TCGA COAD -0.089; TCGA ESCA -0.199; TCGA HNSC -0.101; TCGA KIRC -0.095; TCGA LIHC -0.115; TCGA LUAD -0.161; TCGA PAAD -0.148; TCGA PRAD -0.091; TCGA STAD -0.159; TCGA UCEC -0.102
hsa-miR-125b-5p
RAB3D
13 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.221; TCGA CESC -0.079; TCGA COAD -0.07; TCGA HNSC -0.199; TCGA KIRC -0.224; TCGA KIRP -0.279; TCGA LIHC -0.473; TCGA LUAD -0.129; TCGA LUSC -0.138; TCGA PAAD -0.29; TCGA PRAD -0.113; TCGA SARC -0.21; TCGA UCEC -0.098
hsa-miR-125b-5p
WDR5
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; PRAD; STAD
MirTarget
TCGA BRCA -0.144; TCGA CESC -0.066; TCGA COAD -0.065; TCGA ESCA -0.123; TCGA HNSC -0.06; TCGA LIHC -0.119; TCGA LUSC -0.26; TCGA OV -0.07; TCGA PAAD -0.234; TCGA PRAD -0.054; TCGA STAD -0.15
hsa-miR-125b-5p
DDX54
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUSC; PAAD; STAD; UCEC
MirTarget
TCGA BRCA -0.181; TCGA CESC -0.057; TCGA COAD -0.055; TCGA ESCA -0.132; TCGA HNSC -0.06; TCGA LGG -0.127; TCGA LIHC -0.104; TCGA LUSC -0.194; TCGA PAAD -0.245; TCGA STAD -0.115; TCGA UCEC -0.065
hsa-miR-125b-5p
LASP1
10 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; STAD
mirMAP
TCGA BRCA -0.171; TCGA CESC -0.109; TCGA COAD -0.057; TCGA ESCA -0.283; TCGA HNSC -0.07; TCGA KIRC -0.056; TCGA KIRP -0.08; TCGA LGG -0.118; TCGA LIHC -0.243; TCGA STAD -0.095
hsa-miR-125b-5p
POLR1A
9 cancers: BRCA; CESC; ESCA; HNSC; LIHC; LUSC; PRAD; THCA; STAD
mirMAP
TCGA BRCA -0.07; TCGA CESC -0.141; TCGA ESCA -0.119; TCGA HNSC -0.179; TCGA LIHC -0.155; TCGA LUSC -0.102; TCGA PRAD -0.126; TCGA THCA -0.073; TCGA STAD -0.11
hsa-miR-125b-5p
ITPK1
10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PAAD; SARC; UCEC
mirMAP
TCGA BRCA -0.169; TCGA CESC -0.075; TCGA COAD -0.092; TCGA ESCA -0.271; TCGA HNSC -0.152; TCGA LGG -0.091; TCGA LUSC -0.149; TCGA PAAD -0.12; TCGA SARC -0.254; TCGA UCEC -0.128
hsa-miR-125b-5p
PYCRL
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; STAD; UCEC
mirMAP
TCGA BRCA -0.424; TCGA CESC -0.123; TCGA COAD -0.13; TCGA ESCA -0.238; TCGA HNSC -0.184; TCGA LIHC -0.213; TCGA LUSC -0.191; TCGA OV -0.237; TCGA PAAD -0.436; TCGA STAD -0.135; TCGA UCEC -0.085
hsa-miR-125b-5p
MLEC
11 cancers: BRCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; PAAD; PRAD; THCA; STAD
mirMAP
TCGA BRCA -0.072; TCGA CESC -0.104; TCGA COAD -0.105; TCGA ESCA -0.343; TCGA KIRC -0.182; TCGA LIHC -0.122; TCGA LUAD -0.169; TCGA PAAD -0.122; TCGA PRAD -0.141; TCGA THCA -0.321; TCGA STAD -0.203
hsa-miR-125b-5p
SLC12A7
10 cancers: BRCA; ESCA; KIRC; LIHC; OV; PAAD; PRAD; THCA; STAD; UCEC
mirMAP
TCGA BRCA -0.178; TCGA ESCA -0.208; TCGA KIRC -0.248; TCGA LIHC -0.178; TCGA OV -0.097; TCGA PAAD -0.16; TCGA PRAD -0.082; TCGA THCA -0.109; TCGA STAD -0.183; TCGA UCEC -0.132
hsa-miR-125b-5p
NCLN
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; STAD; UCEC
mirMAP
TCGA BRCA -0.228; TCGA CESC -0.095; TCGA COAD -0.101; TCGA ESCA -0.224; TCGA HNSC -0.199; TCGA KIRP -0.059; TCGA LGG -0.182; TCGA LIHC -0.088; TCGA LUSC -0.128; TCGA OV -0.064; TCGA PAAD -0.378; TCGA STAD -0.155; TCGA UCEC -0.102
hsa-miR-125b-5p
KLF16
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; STAD; UCEC
mirMAP; miRNATAP
TCGA BRCA -0.287; TCGA CESC -0.092; TCGA COAD -0.074; TCGA ESCA -0.161; TCGA HNSC -0.082; TCGA KIRP -0.099; TCGA LIHC -0.108; TCGA LUSC -0.235; TCGA PAAD -0.216; TCGA STAD -0.131; TCGA UCEC -0.085
hsa-miR-125b-5p
CENPO
14 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD; UCEC
mirMAP
TCGA BRCA -0.254; TCGA CESC -0.127; TCGA COAD -0.142; TCGA ESCA -0.204; TCGA HNSC -0.142; TCGA LGG -0.149; TCGA LIHC -0.428; TCGA LUAD -0.132; TCGA LUSC -0.265; TCGA PAAD -0.237; TCGA PRAD -0.27; TCGA THCA -0.094; TCGA STAD -0.107; TCGA UCEC -0.111
hsa-miR-125b-5p
RFT1
10 cancers: BRCA; CESC; COAD; ESCA; HNSC; LIHC; LUSC; OV; PAAD; STAD
mirMAP
TCGA BRCA -0.059; TCGA CESC -0.085; TCGA COAD -0.086; TCGA ESCA -0.151; TCGA HNSC -0.064; TCGA LIHC -0.161; TCGA LUSC -0.102; TCGA OV -0.057; TCGA PAAD -0.161; TCGA STAD -0.1
hsa-miR-125b-5p
SLC27A4
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; THCA; STAD; UCEC
mirMAP; miRNATAP
TCGA BRCA -0.265; TCGA CESC -0.13; TCGA COAD -0.094; TCGA ESCA -0.247; TCGA HNSC -0.305; TCGA LUSC -0.295; TCGA OV -0.126; TCGA PAAD -0.249; TCGA THCA -0.602; TCGA STAD -0.091; TCGA UCEC -0.131
hsa-miR-125b-5p
GMPPB
10 cancers: BRCA; COAD; ESCA; LIHC; OV; PAAD; SARC; THCA; STAD; UCEC
mirMAP
TCGA BRCA -0.235; TCGA COAD -0.107; TCGA ESCA -0.259; TCGA LIHC -0.076; TCGA OV -0.1; TCGA PAAD -0.164; TCGA SARC -0.095; TCGA THCA -0.237; TCGA STAD -0.13; TCGA UCEC -0.109
hsa-miR-125b-5p
LMNB2
10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LIHC; LUSC; PAAD; PRAD; STAD
mirMAP
TCGA BRCA -0.3; TCGA COAD -0.11; TCGA ESCA -0.132; TCGA HNSC -0.126; TCGA KIRP -0.104; TCGA LIHC -0.353; TCGA LUSC -0.236; TCGA PAAD -0.2; TCGA PRAD -0.103; TCGA STAD -0.212
hsa-miR-125b-5p
EPHA10
9 cancers: BRCA; CESC; COAD; ESCA; KIRP; LGG; LIHC; OV; STAD
mirMAP; miRNATAP
TCGA BRCA -0.418; TCGA CESC -0.349; TCGA COAD -0.127; TCGA ESCA -0.683; TCGA KIRP -0.495; TCGA LGG -0.346; TCGA LIHC -0.639; TCGA OV -0.374; TCGA STAD -0.149
hsa-miR-125b-5p
TMEM120B
10 cancers: BRCA; CESC; COAD; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; THCA
mirMAP; miRNATAP
TCGA BRCA -0.106; TCGA CESC -0.128; TCGA COAD -0.071; TCGA KIRP -0.073; TCGA LIHC -0.325; TCGA LUAD -0.096; TCGA LUSC -0.091; TCGA PAAD -0.331; TCGA PRAD -0.086; TCGA THCA -0.129
hsa-miR-125b-5p
NIPA1
14 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BRCA -0.177; TCGA CESC -0.057; TCGA COAD -0.128; TCGA ESCA -0.174; TCGA HNSC -0.112; TCGA KIRC -0.081; TCGA LIHC -0.159; TCGA LUAD -0.104; TCGA LUSC -0.209; TCGA PRAD -0.162; TCGA SARC -0.269; TCGA THCA -0.206; TCGA STAD -0.189; TCGA UCEC -0.139
hsa-miR-125b-5p
UBE2W
10 cancers: BRCA; COAD; HNSC; LUAD; OV; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BRCA -0.082; TCGA COAD -0.071; TCGA HNSC -0.124; TCGA LUAD -0.209; TCGA OV -0.118; TCGA PRAD -0.149; TCGA SARC -0.095; TCGA THCA -0.073; TCGA STAD -0.12; TCGA UCEC -0.072
hsa-miR-125b-5p
MAP3K11
9 cancers: BRCA; COAD; ESCA; HNSC; KIRC; OV; PAAD; STAD; UCEC
miRNATAP
TCGA BRCA -0.128; TCGA COAD -0.065; TCGA ESCA -0.129; TCGA HNSC -0.128; TCGA KIRC -0.191; TCGA OV -0.058; TCGA PAAD -0.188; TCGA STAD -0.062; TCGA UCEC -0.083
hsa-miR-125b-5p
NEU1
12 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; OV; PAAD; THCA; UCEC
miRNATAP
TCGA BRCA -0.221; TCGA CESC -0.16; TCGA ESCA -0.205; TCGA HNSC -0.132; TCGA KIRC -0.104; TCGA LGG -0.108; TCGA LIHC -0.323; TCGA LUAD -0.17; TCGA OV -0.222; TCGA PAAD -0.213; TCGA THCA -0.165; TCGA UCEC -0.211
hsa-miR-125b-5p
TAZ
10 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; UCEC
miRNATAP
TCGA BRCA -0.138; TCGA ESCA -0.089; TCGA KIRC -0.162; TCGA KIRP -0.085; TCGA LGG -0.113; TCGA LIHC -0.189; TCGA LUSC -0.228; TCGA OV -0.089; TCGA PAAD -0.251; TCGA UCEC -0.102
hsa-miR-125b-5p
TMED9
11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LIHC; OV; PAAD; THCA; UCEC
miRNATAP
TCGA BRCA -0.223; TCGA CESC -0.06; TCGA ESCA -0.12; TCGA HNSC -0.081; TCGA KIRC -0.138; TCGA KIRP -0.057; TCGA LIHC -0.175; TCGA OV -0.111; TCGA PAAD -0.252; TCGA THCA -0.083; TCGA UCEC -0.08
hsa-miR-125b-5p
GOLGA5
14 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PRAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BRCA -0.094; TCGA CESC -0.074; TCGA COAD -0.066; TCGA ESCA -0.077; TCGA HNSC -0.124; TCGA LGG -0.055; TCGA LUAD -0.131; TCGA LUSC -0.147; TCGA OV -0.078; TCGA PRAD -0.063; TCGA SARC -0.064; TCGA THCA -0.097; TCGA STAD -0.101; TCGA UCEC -0.072
hsa-miR-125b-5p
SET
10 cancers: BRCA; COAD; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; PRAD; STAD
miRNATAP
TCGA BRCA -0.09; TCGA COAD -0.089; TCGA ESCA -0.094; TCGA HNSC -0.106; TCGA LGG -0.075; TCGA LIHC -0.138; TCGA LUAD -0.093; TCGA LUSC -0.209; TCGA PRAD -0.136; TCGA STAD -0.142
hsa-miR-125b-5p
KCTD5
9 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUSC; PRAD; STAD
miRNATAP
TCGA BRCA -0.191; TCGA CESC -0.065; TCGA COAD -0.103; TCGA ESCA -0.164; TCGA HNSC -0.159; TCGA LGG -0.156; TCGA LUSC -0.135; TCGA PRAD -0.116; TCGA STAD -0.147
hsa-miR-125b-5p
SEC24A
11 cancers: CESC; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.116; TCGA COAD -0.067; TCGA ESCA -0.212; TCGA HNSC -0.138; TCGA KIRC -0.087; TCGA LGG -0.09; TCGA LUAD -0.118; TCGA PRAD -0.149; TCGA THCA -0.164; TCGA STAD -0.15; TCGA UCEC -0.117
hsa-miR-125b-5p
SLC7A1
12 cancers: CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD
miRNAWalker2 validate; MirTarget; miRNATAP
TCGA CESC -0.1; TCGA ESCA -0.15; TCGA HNSC -0.203; TCGA KIRC -0.14; TCGA LGG -0.124; TCGA LIHC -0.549; TCGA LUAD -0.093; TCGA LUSC -0.177; TCGA PAAD -0.134; TCGA SARC -0.137; TCGA THCA -0.275; TCGA STAD -0.205
hsa-miR-125b-5p
SSR3
10 cancers: CESC; COAD; ESCA; HNSC; LIHC; LUAD; OV; PRAD; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.137; TCGA COAD -0.105; TCGA ESCA -0.08; TCGA HNSC -0.154; TCGA LIHC -0.147; TCGA LUAD -0.086; TCGA OV -0.106; TCGA PRAD -0.072; TCGA STAD -0.112; TCGA UCEC -0.058
hsa-miR-125b-5p
TMEM2
10 cancers: CESC; ESCA; HNSC; KIRC; LUAD; OV; PRAD; THCA; STAD; UCEC
miRNAWalker2 validate
TCGA CESC -0.16; TCGA ESCA -0.451; TCGA HNSC -0.098; TCGA KIRC -0.352; TCGA LUAD -0.083; TCGA OV -0.161; TCGA PRAD -0.272; TCGA THCA -0.123; TCGA STAD -0.219; TCGA UCEC -0.128
hsa-miR-125b-5p
CRIPT
9 cancers: CESC; COAD; KIRP; LIHC; LUAD; LUSC; OV; PRAD; UCEC
MirTarget
TCGA CESC -0.073; TCGA COAD -0.055; TCGA KIRP -0.053; TCGA LIHC -0.054; TCGA LUAD -0.189; TCGA LUSC -0.163; TCGA OV -0.1; TCGA PRAD -0.092; TCGA UCEC -0.054
hsa-miR-125b-5p
PCSK7
9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LGG; LIHC; SARC; UCEC
MirTarget; miRNATAP
TCGA CESC -0.073; TCGA COAD -0.084; TCGA ESCA -0.312; TCGA HNSC -0.055; TCGA KIRC -0.117; TCGA LGG -0.098; TCGA LIHC -0.083; TCGA SARC -0.142; TCGA UCEC -0.078
hsa-miR-125b-5p
PCTP
9 cancers: CESC; ESCA; KIRP; LUAD; OV; PAAD; PRAD; THCA; UCEC
MirTarget; miRNATAP
TCGA CESC -0.159; TCGA ESCA -0.24; TCGA KIRP -0.104; TCGA LUAD -0.222; TCGA OV -0.377; TCGA PAAD -0.148; TCGA PRAD -0.255; TCGA THCA -0.149; TCGA UCEC -0.171
hsa-miR-125b-5p
UBE2G1
12 cancers: CESC; COAD; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
MirTarget; miRNATAP
TCGA CESC -0.053; TCGA COAD -0.066; TCGA HNSC -0.085; TCGA KIRP -0.069; TCGA LGG -0.053; TCGA LUAD -0.062; TCGA LUSC -0.18; TCGA PAAD -0.085; TCGA PRAD -0.127; TCGA SARC -0.076; TCGA THCA -0.136; TCGA STAD -0.07
hsa-miR-125b-5p
TIAL1
9 cancers: COAD; KIRC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; STAD
RAID
TCGA COAD -0.065; TCGA KIRC -0.069; TCGA KIRP -0.081; TCGA LGG -0.159; TCGA LUAD -0.116; TCGA LUSC -0.153; TCGA PAAD -0.094; TCGA PRAD -0.108; TCGA STAD -0.098
hsa-miR-125b-5p
STC2
9 cancers: HNSC; KIRC; LGG; LIHC; LUSC; PRAD; SARC; THCA; UCEC
miRNAWalker2 validate
TCGA HNSC -0.445; TCGA KIRC -1.192; TCGA LGG -0.728; TCGA LIHC -0.48; TCGA LUSC -0.49; TCGA PRAD -0.248; TCGA SARC -0.302; TCGA THCA -0.384; TCGA UCEC -0.218





Enriched cancer pathways of putative targets